Document:

Form of Notice of Grant-Early Exercise

 Exhibit 10.4 
 EARLY EXERCISE 
 WHITEGLOVE HOUSE CALL HEALTH, INC. 

NOTICE OF GRANT OF STOCK OPTION 
 Notice is hereby given of the following option grant (the “Option”) to purchase shares (the “Option Shares”) of the Common Stock of Whiteglove House Call
Health, Inc., a Texas corporation (the “Company”): 
  

			
	 Optionee:
	  	«name»
                                         
                                   
		
	 Grant Date:
	  	«granted»                         
                                         
                      
		
	 Vesting Commencement Date:
	  	«VDate»                          
              
		
	 Exercise Price:
	  	«exc_price»
                                         
                per share
		
	 Number of Option Shares:
	  	«Shares_Granted»
                                         
    shares of Common Stock
		
	 Expiration Date:
	  	«expiration»                         
               
		
	 Type of Option:
	  	«ISO»     Incentive Stock Option
		
		  	«NSO»     Non-Statutory Stock Option
		
	 Date Exercisable:
	  	Immediately Exercisable

 Vesting
Schedule: The Option Shares shall initially be unvested and subject to repurchase by the Company at the lower of (i) the Exercise Price paid per share or (ii) the Fair Market Value per share at the time of Optionee’s cessation of
Service. Optionee shall acquire a vested interest in, and the Company’s repurchase right shall accordingly lapse with respect to, (y) one-fourth (1/4th) of the Option Shares on the first anniversary of the Vesting Commencement Date
and (z) an additional one forty-eighth (1/48th) of the Option Shares on the corresponding day of each calendar month thereafter or, if such calendar month does not have a corresponding day, on the last day of such calendar month. The
Option shall not become exercisable for any additional Option Shares following the Optionee’s cessation of Service, except to the extent (if any) specifically authorized by the Plan Administrator in its sole discretion pursuant to an express
written agreement with Optionee. 
 Optionee understands and agrees that the Option is granted subject to and in accordance with
the terms of the Whiteglove House Call Health, Inc. 2007 Stock Option/Stock Issuance Plan (the “Plan”). Optionee further agrees to be bound by the terms of the Plan and the terms of the Option as set forth in the Stock Option
Agreement attached hereto as Exhibit A and the Code Section 409A Waiver and Release attached hereto as Exhibit B. Optionee understands that any 

 
Option Shares purchased under the Option will be subject to the terms set forth in the Stock Purchase Agreement attached hereto as Exhibit C. Optionee hereby acknowledges receipt of a copy
of the Plan in the form attached hereto as Exhibit D and receipt of “Questions and Answers about Option Grants - Early Exercise Options” from the Company. 
 TRANSFER RESTRICTIONS. OPTIONEE HEREBY AGREES THAT ALL OPTION SHARES ACQUIRED UPON THE EXERCISE OF THE OPTION SHALL BE SUBJECT TO CERTAIN REPURCHASE RIGHTS AND RIGHTS OF FIRST REFUSAL EXERCISABLE
BY THE COMPANY AND ITS ASSIGNS. THE TERMS OF SUCH RIGHTS ARE SPECIFIED IN THE ATTACHED STOCK PURCHASE AGREEMENT. 
 At Will
Employment. Nothing in this Notice or in the attached Stock Option Agreement or Plan shall confer upon Optionee any right to continue in Service for any period of specific duration or interfere with or otherwise restrict in any way the rights of
the Company (or any Parent or Subsidiary employing or retaining Optionee) or of Optionee, which rights are hereby expressly reserved by each, to terminate Optionee’s Service at any time for any reason, with or without cause. 

Definitions. All capitalized terms in this Notice shall have the meaning assigned to them in this Notice, in the attached Stock
Option Agreement or in the Plan. 
  

									
	DATED:                     ,
        	 		 	WHITEGLOVE HOUSE CALL HEALTH, INC.
				
		 		 		 	 
		 		 		 	By:	 	Robert A. Fabbio
		 		 		 		 	President and Chief Executive Officer
				
		 		 		 	OPTIONEE
				
	 	 		 		 	 
		 		 		 	«name»
					
		 		 		 	Address:	 	 
					
		 		 		 		 	 
					
		 		 		 	Phone:	 	 
					
		 		 		 	Email:	 	 

 Attachments: 

Exhibit A - Stock Option Agreement 

Exhibit B - Code Section 409A Waiver and Release 

  
 2 

 Exhibit C - Stock Purchase Agreement 
 Exhibit D - 2007 Stock Option/Stock Issuance Plan 

  
 3 

 EXHIBIT A 
 STOCK OPTION AGREEMENT 

 EARLY EXERCISE 
 Whiteglove House Call Health, Inc. 
 STOCK OPTION AGREEMENT

 RECITALS 
 A. The Board has adopted the 2007 Stock Option/Stock Issuance Plan (the “Plan”) for the purpose of retaining the services of selected Employees, non-employee members of the Board
or the board of directors of any Parent or Subsidiary and consultants and other independent advisors in the service of the Company (or any Parent or Subsidiary). 
 B. Optionee is to render valuable services to the Company (or a Parent or Subsidiary), and this Agreement is executed pursuant to, and is intended to carry out the purposes of, the Plan in connection with
the Company’s grant of an option to Optionee. 
 C. All capitalized terms in this Agreement not defined herein shall have
the meaning assigned to them in the Grant Notice (as defined below) or in the Plan. 
 NOW, THEREFORE, it is hereby agreed as
follows: 
 1. Grant of Option. The Company hereby grants to Optionee, as of the date of grant of the option (the
“Grant Date”) as specified in the Notice of Grant of Stock Option accompanying this Agreement, pursuant to which Optionee has been informed of the basic terms of the option evidenced hereby (the “Grant
Notice”), an option to purchase up to the number of the number of Option Shares specified in the Grant Notice. The Option Shares shall be purchasable from time to time during the option term specified in Paragraph 2 at the exercise
price payable per Option Share as specified in the Grant Notice (the “Exercise Price”). 
 2. Option
Term. This option shall have a term of ten (10) years measured from the Grant Date and shall accordingly expire at the close of business on the date on which the option expires as specified in the Grant Notice (the “Expiration
Date”), unless sooner terminated in accordance with Paragraph 5 or 6. 
 3. Limited Transferability.

 (a) This option shall be neither transferable nor assignable by Optionee other than by will or the laws of
inheritance following Optionee’s death and may be exercised, during Optionee’s lifetime, only by Optionee. However, Optionee may designate one or more persons as the beneficiary or beneficiaries of this option, and this option shall, in
accordance with such designation, automatically be transferred to such beneficiary or beneficiaries upon the Optionee’s death while holding this option. Such beneficiary or beneficiaries shall take the transferred option subject to all the
terms and conditions of this Agreement, including (without limitation) the limited time period during which this option may, pursuant to Paragraph 5, be exercised following Optionee’s death. 

  
 Exhibit A -
Page 1 

 (b) If this option is designated a Non-Statutory Option in the Grant Notice,
then this option may be assigned in whole or in part during Optionee’s lifetime to one or more of Optionee’s Family Members or to a trust established for the exclusive benefit of Optionee and/or one or more such Family Members, to the
extent such assignment is in connection with the Optionee’s estate plan or pursuant to a domestic relations order. The assigned portion shall be exercisable only by the person or persons who acquire a proprietary interest in the option pursuant
to such assignment. The terms applicable to the assigned portion shall be the same as those in effect for this option immediately prior to such assignment. 
 4. Dates of Exercise. This option shall become exercisable for the Option Shares in one or more installments as specified in the Grant Notice. As the option becomes exercisable for such
installments, those installments shall accumulate, and the option shall remain exercisable for the accumulated installments until the Expiration Date or sooner termination of the option term under Paragraph 5 or 6. 

5. Cessation of Service. The option term specified in Paragraph 2 shall terminate (and this option shall cease to be outstanding)
prior to the Expiration Date should any of the following provisions become applicable: 
 (a) Should Optionee
cease to remain in Service for any reason (other than death, Disability or Misconduct) while this option is outstanding, then Optionee (or any person or persons to whom this option is transferred pursuant to a permitted transfer under Paragraph 3)
shall have a period of three (3) months (commencing with the date of such cessation of Service) during which to exercise this option, but in no event shall this option be exercisable at any time after the Expiration Date. 

(b) Should Optionee die while this option is outstanding, then the personal representative of Optionee’s estate or
the person or persons to whom the option is transferred pursuant to Optionee’s will or the laws of inheritance following Optionee’s death or, if applicable, the person to whom the option is transferred during Optionee’s lifetime
pursuant to a permitted transfer under Paragraph 3 shall have the right to exercise this option. However, if Optionee dies while holding this option and has an effective beneficiary designation in effect for this option at the time of his or her
death, then the designated beneficiary or beneficiaries shall have the exclusive right to exercise this option following Optionee’s death. Any such right to exercise this option shall lapse, and this option shall cease to be outstanding, upon
the earlier of (i) the expiration of the twelve (12)-month period measured from the date of Optionee’s death or (ii) the Expiration Date. 
 (c) Should Optionee cease Service by reason of Disability while this option is outstanding, then Optionee (or any person or persons to whom this option is transferred pursuant to a permitted transfer
under Paragraph 3) shall have a period of twelve (12) months (commencing with the date of such cessation of Service) during which to exercise this option. In no event shall this option be exercisable at any time after the Expiration Date.

  
 Exhibit A -
Page 2 

 Note: Exercise of this option on a date later than three (3) months following
cessation of Service due to Disability will result in loss of favorable Incentive Option treatment, unless such Disability constitutes Permanent Disability. In the event that Incentive Option treatment is not available, this option will be taxed as
a Non-Statutory Option upon exercise. 
 (d) During the limited period of post-Service exercisability, this
option may not be exercised in the aggregate for more than the number of Option Shares in which Optionee is, at the time of Optionee’s cessation of Service, vested pursuant to the Vesting Schedule specified in the Grant Notice or the special
vesting acceleration provisions of Paragraph 6. No additional Option Shares shall vest, whether pursuant to the normal Vesting Schedule specified in the Grant Notice or the special vesting acceleration provisions of Paragraph 6, following
Optionee’s cessation of Service, except to the extent (if any) specifically authorized by the Plan Administrator pursuant to an express written agreement with Optionee. Upon the expiration of such limited exercise period or (if earlier) upon
the Expiration Date, this option shall terminate and cease to be outstanding for any vested Option Shares for which the option has not been exercised. 
 (e) Should Optionee’s Service be terminated for Misconduct or should Optionee otherwise engage in Misconduct while this option is outstanding, then this option shall terminate immediately and cease
to remain outstanding. 
 6. Change in Control. 

(a) Should a Change in Control occur during Optionee’s period of Service, then the Option Shares at the time subject
to this option but not otherwise vested shall automatically vest in full so that this option shall, immediately prior to the effective date of the Change in Control, become exercisable for all of the Option Shares as fully vested shares and may be
exercised for any or all of those Option Shares as vested shares. However, the Option Shares shall not vest on such an accelerated basis if and to the extent: (i) this option is assumed by the successor corporation (or parent thereof) or
otherwise continued in full force and effect pursuant to the terms of the Change in Control transaction and the Company’s repurchase rights with respect to the unvested Option Shares are assigned to such successor corporation (or parent
thereof) or otherwise continued in effect or (ii) this option is to be replaced with a cash retention program of the successor corporation which preserves the spread existing on the unvested Option Shares at the time of the Change in Control
(the excess of the Fair Market Value of those Option Shares over the Exercise Price payable for such shares) and provides for subsequent payout of that spread in accordance with the same Vesting Schedule applicable to those unvested Option Shares as
set forth in the Grant Notice. 
 (b) Immediately following the Change in Control, this option shall terminate
and cease to be outstanding, except to the extent assumed by the successor corporation (or parent thereof) or otherwise continued in full force and effect pursuant to the terms of the Change in Control transaction. 

  
 Exhibit A -
Page 3 

 (c) If this option is assumed in connection with a Change in Control or
otherwise continued in effect, then this option shall be appropriately adjusted, immediately after such Change in Control, to apply to the number and class of securities which would have been issuable to Optionee in consummation of such Change in
Control had the option been exercised immediately prior to such Change in Control, and appropriate adjustments shall also be made to the Exercise Price, provided the aggregate Exercise Price shall remain the same. To the extent that the
actual holders of the Company’s outstanding Common Stock receive cash consideration for their Common Stock in consummation of the Change in Control, the successor corporation may, in connection with the assumption or continuation of this
option, substitute one or more shares of its own common stock with a fair market value equivalent to the cash consideration paid per share of Common Stock in such Change in Control. 

(d) This Agreement shall not in any way affect the right of the Company to adjust, reclassify, reorganize or otherwise
change its capital or business structure or to merge, consolidate, dissolve, liquidate or sell or transfer all or any part of its business or assets. 
 7. Adjustment in Option Shares. In the event of any of the following transactions affecting the outstanding Common Stock as a class without the Company’s receipt of consideration: any stock
split, stock dividend, spin-off transaction, extraordinary distribution (whether in cash, securities or other property), recapitalization, combination of shares, exchange of shares or other similar transaction affecting the Common Stock without the
Company’s receipt of consideration, then equitable adjustments shall be made to (i) the total number and/or class of securities subject to this option and (ii) the Exercise Price. The adjustments shall be made by the Plan
Administrator in such manner as the Plan Administrator deems appropriate in order to reflect such change and thereby preclude a dilution or enlargement of benefits hereunder. 
 8. Stockholder Rights. The holder of this option shall not have any stockholder rights with respect to the Option Shares until such person shall have exercised the option, paid the Exercise Price
and become the record holder of the purchased shares. 
 9. Manner of Exercising Option. 

(a) In order to exercise this option with respect to all or any part of the Option Shares for which this option is at the
time exercisable, Optionee (or any other person or persons exercising the option) must take the following actions: 
 (i) Execute and deliver to the Company a stock purchase agreement substantially in the form of Exhibit C to the Grant Notice (the “Purchase Agreement”) for the Option Shares
for which the option is exercised. 
 (ii) Pay the aggregate Exercise Price for the purchased shares in one or
more of the following forms: 
 (A) cash or check made payable to the Company; or 

  
 Exhibit A -
Page 4 

 (B) a promissory note payable to the Company, but only to the extent
authorized by the Plan Administrator in accordance with Paragraph 14. 
 Should the Common Stock be registered
under Section 12 of the 1934 Act at the time the option is exercised, then the Exercise Price may also be paid as follows: 
 (C) in shares of Common Stock valued at Fair Market Value on the Exercise Date and held by Optionee (or any other person or persons exercising the option) for the period (if any) necessary to avoid a
charge to the Company’s earnings for financial reporting purposes; or 
 (D) to the extent the option is
exercised for vested Option Shares, through a special sale and remittance procedure pursuant to which Optionee (or any other person or persons exercising the option) shall concurrently provide irrevocable instructions (a) to a brokerage firm
(reasonably satisfactory to the Company for purposes of administering such procedure in compliance with any applicable pre-clearance or pre-notification requirements) to effect the immediate sale of the purchased shares and remit to the Company, out
of the sale proceeds available on the settlement date, sufficient funds to cover the aggregate Exercise Price payable for the purchased shares plus all applicable income and employment taxes required to be withheld by the Company by reason of such
exercise and (b) to the Company to deliver the certificates for the purchased shares directly to such brokerage firm on such settlement date in order to complete the sale. 

Except to the extent the sale and remittance procedure is utilized in connection with the option exercise, payment of the
Exercise Price must accompany the Purchase Agreement delivered to the Company in connection with the option exercise. 
 (iii) Furnish to the Company appropriate documentation that the person or persons exercising the option (if other than Optionee) have the right to exercise this option. 

(iv) Execute and deliver to the Company such written representations as may be requested by the Company in order for it to
comply with the applicable requirements of applicable securities laws. 
 (v) Make appropriate arrangements with
the Company (or Parent or Subsidiary employing or retaining Optionee) for the satisfaction of all applicable income and employment tax withholding requirements applicable to the option exercise. 

(b) As soon as practical after the date on which the options shall have been exercised in accordance with this Paragraph 9
(the “Exercise Date”), the Company shall issue to or on behalf of Optionee (or any other person or persons exercising this option) a certificate for the purchased Option Shares, with the appropriate legends affixed thereto.

  
 Exhibit A -
Page 5 

 (c) In no event may this option be exercised for any fractional shares.

 10. REPURCHASE RIGHTS. ALL OPTION SHARES ACQUIRED UPON THE EXERCISE OF THIS OPTION SHALL BE SUBJECT TO CERTAIN RIGHTS
OF THE COMPANY AND ITS ASSIGNS TO REPURCHASE THOSE SHARES IN ACCORDANCE WITH THE TERMS SPECIFIED IN THE PURCHASE AGREEMENT. 

11. Compliance with Laws and Regulations. 
 (a) The exercise of this option and the issuance of the Option Shares upon such exercise shall be subject to compliance by the Company and Optionee with all applicable requirements of law relating thereto
and with all applicable regulations of any stock exchange (or the Nasdaq National Market, if applicable) on which the Common Stock may be listed for trading at the time of such exercise and issuance. 

(b) The inability of the Company to obtain approval from any regulatory body having authority deemed by the Company to be
necessary to the lawful issuance and sale of any Common Stock pursuant to this option shall relieve the Company of any liability with respect to the non-issuance or sale of the Common Stock as to which such approval shall not have been obtained. The
Company, however, shall use its best efforts to obtain all such approvals. 
 12. Successors and Assigns. Except to the
extent otherwise provided in Paragraphs 3 and 6, the provisions of this Agreement shall inure to the benefit of, and be binding upon, the Company and its successors and assigns and Optionee, Optionee’s assigns and the legal representatives,
heirs and legatees of Optionee’s estate. 
 13. Notices. Any notice required to be given or delivered to the Company
under the terms of this Agreement shall be in writing and addressed to the Company at its principal corporate offices. Any notice required to be given or delivered to Optionee shall be in writing and addressed to Optionee at the address indicated
below Optionee’s signature line on the Grant Notice. All notices shall be deemed effective upon personal delivery or upon deposit in the U.S. mail, postage prepaid and properly addressed to the party to be notified. 

Optionee generally consents to the delivery of any notice pursuant to the Texas Business Organizations Code (the
“TBOC”), as amended or superseded from time to time, by electronic transmission pursuant to Section 6.051 of the TBOC (“Electronic Notice”) at the electronic mail address or the facsimile number
as set forth in the books of the Company. To the extent that any notice given via electronic transmission is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected electronic
mail address has been provided, and such attempted Electronic Notice shall be ineffective and deemed to not have been given. Optionee agrees to promptly notify the Company of any change in Optionee’s electronic mail address, but failure to do
so shall not affect the foregoing. 

  
 Exhibit A -
Page 6 

 14. Financing. The Plan Administrator may, in its absolute discretion and without any
obligation to do so, permit Optionee to pay the Exercise Price for the purchased Option Shares by delivering a full-recourse promissory note bearing interest at a market rate and secured by those Option Shares. The payment schedule in effect for any
such promissory note shall be established by the Plan Administrator in its sole discretion. 
 15. Construction. This
Agreement and the option evidenced hereby are made and granted pursuant to the Plan and are in all respects limited by and subject to the terms of the Plan. All decisions of the Plan Administrator with respect to any question or issue arising under
the Plan or this Agreement shall be conclusive and binding on all persons having an interest in this option. 
 16. Governing
Law. The interpretation, performance and enforcement of this Agreement shall be governed by the laws of the State of Texas without resort to that state’s conflict-of-laws rules. 

17. Stockholder Approval. If the Option Shares covered by this Agreement exceed, as of the Grant Date, the number of shares of
Common Stock which may be issued under the Plan as last approved by the stockholders, then this option shall be void with respect to such excess shares, unless stockholder approval of an amendment sufficiently increasing the number of shares of
Common Stock issuable under the Plan is obtained in accordance with the provisions of the Plan. 
 18. Additional Terms
Applicable to an Incentive Option. In the event this option is designated an Incentive Option in the Grant Notice, the following terms and conditions shall also apply to the grant: 

(a) This option shall cease to qualify for favorable tax treatment as an Incentive Option if (and to the extent) this
option is exercised for one or more Option Shares: (i) more than three (3) months after the date Optionee ceases to be an Employee for any reason other than death or Permanent Disability or (ii) more than twelve (12) months after
the date Optionee ceases to be an Employee by reason of Permanent Disability. 
 (b) This option shall not become
exercisable in the calendar year in which granted if (and to the extent) the aggregate Fair Market Value (determined at the Grant Date) of the Common Stock for which this option would otherwise first become exercisable in such calendar year would,
when added to the aggregate value (determined as of the respective date or dates of grant) of the Common Stock and any other securities for which one or more other Incentive Options granted to Optionee prior to the Grant Date (whether under the Plan
or any other option plan of the Company or any Parent or Subsidiary) first become exercisable during the same calendar year, exceed One Hundred Thousand Dollars ($100,000) in the aggregate. To the extent the exercisability of this option is deferred
by reason of the foregoing limitation, the deferred portion shall become exercisable in the first calendar year or years thereafter in which the One Hundred Thousand Dollar ($100,000) limitation of this Paragraph 18(b) would not be contravened, but
such deferral shall in all events end immediately prior to the effective date of a Change in Control in which this option is not to be assumed or otherwise continued in effect, whereupon the option shall become immediately exercisable as a
Non-Statutory Option for the deferred portion of the Option Shares. 

  
 Exhibit A -
Page 7 

 (c) Should Optionee hold, in addition to this option, one or more other
options to purchase Common Stock which become exercisable for the first time in the same calendar year as this option, then for purposes of the foregoing limitations on the exercisability of such options as Incentive Options, this option and each of
those other options shall be deemed to become first exercisable in that calendar year on the basis of the chronological order in which they were granted, except to the extent otherwise provided under applicable law or regulation. 

  
 Exhibit A -
Page 8 

 EXHIBIT B 
 CODE SECTION 409A WAIVER AND RELEASE 

 EARLY EXERCISE 
 Whiteglove House Call Health, Inc. 
 CODE SECTION 409A WAIVER AND RELEASE

 THIS WAIVER AND RELEASE (this “Waiver”) made as of this
         day of                     , 20     , by
«name», the holder of a stock option under the Company’s 2007 Stock Option/Stock Issuance Plan. 
 All
capitalized terms in this Waiver not defined herein shall have the meaning assigned to them in the Notice to which this Waiver is attached or in the Plan. 
 Optionee hereby agrees and acknowledges that the Company’s Board has taken reasonable steps to value the Common Stock and to set the Exercise Price at the Fair Market Value per share of Common Stock
on the Grant Date so that the Option will not be treated as an item of deferred compensation subject to Code Section 409A. However, because the Common Stock is not readily tradable on an established securities market, there can be no assurance
that the Exercise Price is at least equal to the Fair Market Value per share of Common Stock on the Grant Date. Were the Internal Revenue Service to conclude that the Exercise Price is in fact less than such Fair Market Value and that the Option is
accordingly subject to Code Section 409A, then Optionee would be subject the following adverse tax consequences: 
 (i) As the Option vests in accordance with the Vesting Schedule, Optionee would immediately recognize taxable income for federal income tax purposes equal to the amount by which the Fair Market Value of
the Option Shares which vest at that time exceeds the Exercise Price payable for those shares. The Company would also have to collect from Optionee the federal income and employment taxes which must be withheld on that income. Taxation would occur
in this manner even though the Option remains unexercised. 
 (ii) Optionee may also be subject to additional
income taxation and withholding taxes on any subsequent increases to the Fair Market Value of the Option Shares purchasable under the vested Option until the Option is exercised or cancelled as to those Option Shares. 

(iii) In addition to normal income taxes payable as the Option vests, Optionee would also be subject to an additional tax
penalty equal to 20% of the amount of income Optionee recognizes under Code Section 409A when the Option vests and may also be subject to such penalty as the underlying Option Shares subsequently increase in Fair Market Value over the period
the Option continues to remain outstanding. 
 (iv) There will also be interest penalties if the resulting taxes
are not paid on a timely basis. 

  
 Exhibit B -
Page 1 

 Optionee hereby further agrees and acknowledges that Optionee will incur the same tax
consequences, including (without limitation) a second 20% penalty tax, under California income tax laws if Optionee is a resident of the State of California or is otherwise subject to California income taxation. If the Optionee is a resident of any
other state, he or she accepts the risk of any unfavorable tax consequences under the laws of that state applicable to options granted with an Exercise Price less than the Fair Market Value of the Option Shares on the Grant Date. 

Optionee hereby agrees to bear the entire risk of such adverse federal and state tax consequences in the event the Option is deemed to be
subject to Code Section 409A and hereby knowingly and voluntarily, in consideration for the grant of the Option, waives and releases any and all claims or causes of action that Optionee might otherwise have against the Company and/or the Board,
officers, employees or stockholders arising from or relating to the tax treatment of the Option under Code Section 409A and the corresponding provisions of any applicable state income tax laws (including, without limitation, California income
tax laws) and shall not seek any indemnification or other recovery of damages against the Company and/or the Board, officers, employees or stockholders with respect to any adverse federal and state tax consequences or other related costs and
expenses Optionee may in fact incur under Code Section 409A (or the corresponding provisions of state income tax laws) as a result of the Option. 
 IN WITNESS WHEREOF, the undersigned Optionee has executed this Waiver on the date and year first indicated above. 

 

			
	OPTIONEE
	
	 
	«name»
		
	Address:	 	 
		
		 	 

  
 Exhibit B -
Page 2 

 EXHIBIT C 
 STOCK PURCHASE AGREEMENT 

 EARLY EXERCISE 
 Whiteglove House Call Health, Inc. 
 STOCK PURCHASE AGREEMENT

 AGREEMENT made this      day of
                                    , 20
       by and between Whiteglove House Call Health, Inc., a Texas corporation, and «name», Optionee under the Company’s 2007 Stock Option/Stock Issuance Plan. 

All capitalized terms in this Agreement shall have the meaning assigned to them in this Agreement or in the Plan attached as Exhibit
D to the Notice of Grant to which this Agreement relates. 
  

	A.	EXERCISE OF OPTION 

 1.
Exercise. Optionee hereby purchases              shares of Common Stock (the “Purchased Shares”) pursuant to that certain option (the
“Option”) granted Optionee on «granted» (the “Grant Date”) to purchase up to «Shares_Granted» shares of Common Stock (the “Option Shares”) under
the Plan at the exercise price of «exc_price» per share (the “Exercise Price”). 
 2.
Payment. Concurrently with the delivery of this Agreement to the Company, Optionee shall pay the Exercise Price for the Purchased Shares in accordance with the provisions of all agreements and other documents evidencing the Option (the
“Option Agreement”) and shall deliver whatever additional documents may be required by the Option Agreement as a condition for exercise, together with a duly-executed blank Assignment Separate from Certificate (in the form
attached hereto as Exhibit I) with respect to the Purchased Shares. 
 3. Stockholder Rights. Until such time
as the Company exercises the Repurchase Right or the First Refusal Right, Optionee (or any successor in interest) shall have all the rights of a stockholder (including voting, dividend and liquidation rights) with respect to the Purchased Shares,
subject, however, to the transfer restrictions of Articles B and C. 
 4. Information. Optionee believes it has
received all the information it considers necessary or appropriate for deciding whether to purchase the Purchased Shares. Optionee further represents that such Optionee has had an opportunity to ask questions and receive answers from the Company
regarding the terms and conditions of the offering of the Purchased Shares and the business, properties, prospects and financial condition of the Company. Optionee acknowledges that it has been furnished separately “Questions and Answers about
Option Grants - Early Exercise Options” by the Company. 
  

	B.	SECURITIES LAW COMPLIANCE 

1. Restricted Securities. The Purchased Shares have not been registered under the Securities Act of 1933, as amended (the
“1933 Act”) and are being issued to Optionee in reliance upon the exemption from such registration provided by Rule 701 of the Securities and Exchange Commission (the “SEC”) for stock issuances under
compensatory benefit plans such as the Plan. Optionee hereby confirms that Optionee has been informed that the Purchased Shares are restricted securities under the 1933 Act and may not be resold or transferred unless the

  
 Exhibit C -
Page 1 

 
Purchased Shares are first registered under the federal securities laws or unless an exemption from such registration is available. Accordingly, Optionee hereby acknowledges that Optionee is
acquiring the Purchased Shares for investment purposes only and not with a view to resale and is prepared to hold the Purchased Shares for an indefinite period and that Optionee is aware that SEC Rule 144 issued under the 1933 Act which exempts
certain resales of unrestricted securities is not presently available to exempt the resale of the Purchased Shares from the registration requirements of the 1933 Act. 
 2. Restrictions on Disposition of Purchased Shares. Optionee shall make no disposition of the Purchased Shares (other than a Permitted Transfer) unless and until there is compliance with all of the
following requirements: 
 (i) Optionee shall have provided the Company with a written summary of the terms and
conditions of the proposed disposition. 
 (ii) Optionee shall have complied with all requirements of this
Agreement applicable to the disposition of the Purchased Shares. 
 (iii) Optionee shall have provided the
Company with written assurances, in form and substance satisfactory to the Company, that (a) the proposed disposition does not require registration of the Purchased Shares under the 1933 Act or (b) all appropriate action necessary for
compliance with the registration requirements of the 1933 Act or any exemption from registration available under the 1933 Act (including Rule 144) has been taken. 
 The Company shall not be required (i) to transfer on its books any Purchased Shares which have been sold or transferred in violation of the provisions of this Agreement or (ii) to treat as the
owner of the Purchased Shares, or otherwise to accord voting, dividend or liquidation rights to, any transferee to whom the Purchased Shares have been transferred in contravention of this Agreement. 

3. Restrictive Legends. The stock certificates for the Purchased Shares shall be endorsed with one or more of the following
restrictive legends: 
 THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933. THE
SHARES MAY NOT BE SOLD OR OFFERED FOR SALE IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SHARES UNDER SUCH ACT, (B) A ‘NO ACTION’ LETTER OF THE SECURITIES AND EXCHANGE COMMISSION WITH RESPECT TO SUCH SALE OR
OFFER OR (C) SATISFACTORY ASSURANCES TO THE COMPANY THAT REGISTRATION UNDER SUCH ACT IS NOT REQUIRED WITH RESPECT TO SUCH SALE OR OFFER. 
 THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN REPURCHASE RIGHTS AND RIGHTS OF FIRST REFUSAL GRANTED TO THE COMPANY AND ACCORDINGLY MAY NOT BE SOLD, ASSIGNED, TRANSFERRED, ENCUMBERED,
OR IN ANY 

  
 Exhibit C -
Page 2 

 
MANNER DISPOSED OF EXCEPT IN CONFORMITY WITH THE TERMS OF A STOCK PURCHASE AGREEMENT BETWEEN THE COMPANY AND THE REGISTERED HOLDER OF THE SHARES (OR THE PREDECESSOR IN INTEREST TO THE SHARES). A
COPY OF SUCH AGREEMENT IS MAINTAINED AT THE COMPANY’S PRINCIPAL CORPORATE OFFICES. 
  

	C.	TRANSFER RESTRICTIONS 

 1.
Restriction on Transfer. Except for any Permitted Transfer, Optionee shall not transfer, assign, encumber or otherwise dispose of any of the Purchased Shares which are subject to the Repurchase Right. In addition, Purchased Shares which are
released from the Repurchase Right shall not be transferred, assigned, encumbered or otherwise disposed of in contravention of the First Refusal Right or the Market Stand-Off. 
 2. Transferee Obligations. Each person (other than the Company) to whom the Purchased Shares are transferred by means of a Permitted Transfer must, as a condition precedent to the validity of such
transfer, acknowledge in writing to the Company that such person is bound by the provisions of this Agreement and that the transferred shares are subject to (i) the Repurchase Right, (ii) the First Refusal Right and (iii) the Market
Stand-Off, to the same extent such shares would be so subject if retained by Optionee. 
 3. Market Stand-Off.

 (a) In connection with any underwritten public offering by the Company of its equity securities pursuant to an
effective registration statement filed under the 1933 Act, including the Company’s initial public offering, Optionee and all subsequent holders of the Purchased Shares who derive their chain of ownership through a Permitted Transfer from
Optionee (the “Owner”) shall not (i) lend, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or
otherwise transfer or dispose of, directly or indirectly, any securities of the Company, including (without limitation) shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock (whether now owned or
hereafter acquired) or (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any securities of the Company, including (without limitation) shares of Common
Stock or any securities convertible into or exercisable or exchangeable for Common Stock (whether now owned or hereafter acquired), whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of
securities, in cash or otherwise without the prior written consent of the Company or its underwriters. Such restriction (the “Market Stand-Off”) shall be in effect for such period of time from and after the effective date of
the final prospectus for the offering as may be requested by the Company or such underwriters. In no event, however, shall such period exceed one hundred eighty (180) days, and the Market Stand-Off shall in no event be applicable to any
underwritten public offering effected more than two (2) years after the effective date of the Company’s initial public offering. 
 (b) Owner shall be subject to the Market Stand-Off provided and only if the officers and directors of the Company are also subject to similar restrictions. 

  
 Exhibit C -
Page 3 

 (c) Any new, substituted or additional securities which are by reason of any
Recapitalization or Reorganization distributed with respect to the Purchased Shares shall be immediately subject to the Market Stand-Off, to the same extent the Purchased Shares are at such time covered by such provisions. 

(d) In order to enforce the Market Stand-Off, the Company may impose stop-transfer instructions with respect to the
Purchased Shares until the end of the applicable stand-off period. 
  

	D.	REPURCHASE RIGHT 

 1.
Grant. The Company is hereby granted the right (the “Repurchase Right”), exercisable at any time during the sixty (60)-day period following the date Optionee ceases for any reason to remain in Service or (if later)
during the sixty (60)-day period following the execution date of this Agreement, to repurchase at the lower of (i) the Exercise Price or (ii) the Fair Market Value per share of Common Stock on the date of Optionee’s cessation of
Service (the “Repurchase Price”) any or all of the Purchased Shares in which Optionee is not, at the time of his or her cessation of Service, vested in accordance with the Vesting Schedule applicable to those shares or the
special vesting acceleration provisions of Paragraph D.6 of this Agreement (such shares to be hereinafter referred to as the “Unvested Shares”). 
 2. Exercise of the Repurchase Right. The Repurchase Right shall be exercisable by written notice delivered to each Owner of the Unvested Shares prior to the expiration of the sixty (60)-day
exercise period. The notice shall indicate the number of Unvested Shares to be repurchased, the Repurchase Price to be paid per share and the date on which the repurchase is to be effected, such date to be not more than thirty (30) days after
the date of such notice. The certificates representing the Unvested Shares to be repurchased shall be delivered to the Company on the closing date specified for the repurchase. Concurrently with the receipt of such stock certificates, the Company
shall pay to Owner, in cash or cash equivalents (including the cancellation of any purchase-money indebtedness), an amount equal to the Repurchase Price for the Unvested Shares which are to be repurchased from Owner. 

3. Termination of the Repurchase Right. The Repurchase Right shall terminate with respect to any Unvested Shares for which it is
not timely exercised under Paragraph D.2. In addition, the Repurchase Right shall terminate and cease to be exercisable with respect to any and all Purchased Shares in which Optionee vests in accordance with the Vesting Schedule. All Purchased
Shares as to which the Repurchase Right lapses shall, however, remain subject to (i) the First Refusal Right and (ii) the Market Stand-Off. 
 4. Aggregate Vesting Limitation. If the Option is exercised in more than one increment so that Optionee is a party to one or more other Stock Purchase Agreements (the “Prior Purchase
Agreements”) which are executed prior to the date of this Agreement, then the total number of Purchased Shares as to which Optionee shall be deemed to have a fully-vested interest under this Agreement and all Prior Purchase Agreements
shall not exceed in the aggregate the number of Purchased Shares in which Optionee would otherwise at the time be vested, in accordance with the Vesting Schedule, had all the Purchased Shares (including those acquired under the Prior Purchase
Agreements) been acquired exclusively under this Agreement. 

  
 Exhibit C -
Page 4 

 5. Recapitalization. Any new, substituted or additional securities or other property
(including cash paid other than as a regular cash dividend) which is by reason of any Recapitalization distributed with respect to the Purchased Shares shall be immediately subject to the Repurchase Right and any escrow requirements hereunder, but
only to the extent the Purchased Shares are at the time covered by such right or escrow requirements. Appropriate adjustments to reflect such distribution shall be made to the number and/or class of Purchased Shares subject to this Agreement and to
the Repurchase Price per share to be paid upon the exercise of the Repurchase Right in order to reflect the effect of any such Recapitalization upon the Company’s capital structure; provided, however, that the aggregate Repurchase Price shall
remain the same. 
 6. Change in Control. 

(a) The Repurchase Right shall automatically terminate in its entirety, and all the Purchased Shares shall vest in full,
immediately prior to the consummation of any Change in Control, except to the extent the Repurchase Right is to be assigned to the successor entity in such Change in Control or otherwise continued in full force and effect pursuant to the terms of
the Change in Control transaction. 
 (b) To the extent the Repurchase Right remains in effect following a Change
in Control, such right shall apply to any new securities or other property (including any cash payments) received in exchange for the Purchased Shares in consummation of the Change in Control, but only to the extent the Purchased Shares are at the
time covered by such right. Appropriate adjustments shall be made to the Repurchase Price per share payable upon exercise of the Repurchase Right to reflect the effect (if any) of the Change in Control upon the Company’s capital structure;
provided, however, that the aggregate Repurchase Price shall remain the same. The new securities or other property (including any cash payments) issued or distributed with respect to the Purchased Shares in consummation of the Change in
Control shall be immediately deposited in escrow with the Company (or the successor entity) and shall not be released from escrow until Optionee vests in such securities or other property in accordance with the same Vesting Schedule in effect for
the Purchased Shares. 
  

	E.	RIGHT OF FIRST REFUSAL 

1. Grant. The Company is hereby granted the right of first refusal (the “First Refusal Right”), exercisable
in connection with any proposed transfer of the Purchased Shares in which Optionee has vested in accordance with the provisions of Article D. For purposes of this Article E, the term “transfer” shall include any
sale, assignment, pledge, encumbrance or other disposition of the Purchased Shares intended to be made by Owner, but shall not include any Permitted Transfer. 
 2. Notice of Intended Disposition. In the event any Owner of Purchased Shares in which Optionee has vested desires to accept a bona fide third-party offer for the transfer of any or all of such
shares (the Purchased Shares subject to such offer to be hereinafter referred to as the “Target Shares”), Owner shall promptly (i) deliver to the Company written notice (the “Disposition Notice”)
of the terms of the offer, including the purchase price and the identity of the third-party offeror, and (ii) provide satisfactory proof that the disposition of the Target Shares to such third-party offeror would not be in contravention of the
provisions set forth in Articles B and C. 

  
 Exhibit C -
Page 5 

 3. Exercise of the First Refusal Right. The Company shall, for a period of
twenty-five (25) days following receipt of the Disposition Notice, have the right to repurchase any or all of the Target Shares subject to the Disposition Notice upon the same terms as those specified therein or upon such other terms (not
materially different from those specified in the Disposition Notice) to which Owner consents. Such right shall be exercisable by delivery of written notice (the “Exercise Notice”) to Owner prior to the expiration of the
twenty-five (25)-day exercise period. If such right is exercised with respect to all the Target Shares, then the Company shall effect the repurchase of such shares, including payment of the purchase price, not more than five (5) business days
after delivery of the Exercise Notice; and at such time the certificates representing the Target Shares shall be delivered to the Company. 
 Should the purchase price specified in the Disposition Notice be payable in property other than cash or evidences of indebtedness, the Company shall have the right to pay the purchase price in the form of
cash equal in amount to the value of such property. If Owner and the Company cannot agree on such cash value within ten (10) days after the Company’s receipt of the Disposition Notice, the valuation shall be made by an appraiser of
recognized standing selected by Owner and the Company or, if they cannot agree on an appraiser within twenty (20) days after the Company’s receipt of the Disposition Notice, each shall select an appraiser of recognized standing and the two
(2) appraisers shall designate a third appraiser of recognized standing, whose appraisal shall be determinative of such value. The cost of such appraisal shall be shared equally by Owner and the Company. The closing shall then be held on the
later of (i) the fifth (5th) business day following delivery of the Exercise Notice or (ii) the fifth (5th) business day after such valuation shall have been made. 

4. Non-Exercise of the First Refusal Right. In the event the Exercise Notice is not given to Owner prior to the expiration of the
twenty-five (25)-day exercise period, Owner shall have a period of thirty (30) days thereafter in which to sell or otherwise dispose of the Target Shares to the third-party offeror identified in the Disposition Notice upon terms (including the
purchase price) no more favorable to such third-party offeror than those specified in the Disposition Notice; provided, however, that any such sale or disposition must not be effected in contravention of the provisions of Articles B and C. The
third-party offeror shall acquire the Target Shares subject to the First Refusal Right and the provisions and restrictions of Article B and Paragraph C.3, and any subsequent disposition of the acquired shares must be effected in compliance
with the terms and conditions of such First Refusal Right and the provisions and restrictions of Article B and Paragraph C.3. In the event Owner does not effect such sale or disposition of the Target Shares within the specified thirty
(30)-day period, the First Refusal Right shall continue to be applicable to any subsequent disposition of the Target Shares by Owner until such right lapses. 
 5. Partial Exercise of the First Refusal Right. In the event the Company makes a timely exercise of the First Refusal Right with respect to a portion, but not all, of the Target Shares specified in
the Disposition Notice, Owner shall have the option, exercisable by written notice to the Company delivered within five (5) business days after Owner’s receipt of the Exercise Notice, to effect the sale of the Target Shares pursuant to
either of the following alternatives: 
 (i) sale or other disposition of all the Target Shares to the
third-party offeror identified in the Disposition Notice, but in full compliance with the requirements of Paragraph E.4, as if the Company did not exercise the First Refusal Right; or 

  
 Exhibit C -
Page 6 

 (ii) sale to the Company of the portion of the Target Shares which the
Company has elected to purchase, such sale to be effected in substantial conformity with the provisions of Paragraph E.3. The First Refusal Right shall continue to be applicable to any subsequent disposition of the remaining Target Shares until
such right lapses. 
 Owner’s failure to deliver timely notification to the Company shall be deemed to be an
election by Owner to sell the Target Shares pursuant to alternative (i) above. 
 6.
Recapitalization/Reorganization. 
 (a) Any new, substituted or additional securities or other property
which is by reason of any Recapitalization distributed with respect to the Purchased Shares shall be immediately subject to the First Refusal Right, but only to the extent the Purchased Shares are at the time covered by such right. 

(b) In the event of a Reorganization, the First Refusal Right shall remain in full force and effect and shall apply to the
new capital stock or other property received in exchange for the Purchased Shares in consummation of the Reorganization, but only to the extent the Purchased Shares are at the time covered by such right. 

7. Lapse. The First Refusal Right shall lapse upon the earliest to occur of (i) the first date on which shares of the Common
Stock are held of record by more than five hundred (500) persons, (ii) a determination made by the Board that a public market exists for the outstanding shares of Common Stock, (iii) a firm commitment underwritten public offering,
pursuant to an effective registration statement under the 1933 Act, covering the offer and sale of the Common Stock in the aggregate amount of at least twenty million dollars ($20,000,000) or (iv) the closing of a Change in Control. However,
the Market Stand-Off shall continue to remain in full force and effect following the lapse of the First Refusal Right. 
  

	F.	SPECIAL TAX ELECTION 

 The
acquisition of the Purchased Shares may result in adverse tax consequences which may be avoided or mitigated by filing an election under Code Section 83(b). Such election must be filed within thirty (30) days after the date of this
Agreement. A description of the tax consequences applicable to the acquisition of the Purchased Shares and the form for making the Code Section 83(b) election are set forth in Exhibit II. OPTIONEE SHOULD CONSULT WITH HIS OR HER TAX
ADVISOR TO DETERMINE THE TAX CONSEQUENCES OF ACQUIRING THE PURCHASED SHARES AND THE ADVANTAGES AND DISADVANTAGES OF FILING THE CODE SECTION 83(b) ELECTION. OPTIONEE ACKNOWLEDGES THAT IT IS OPTIONEE’S SOLE RESPONSIBILITY, AND NOT THE
COMPANY’S, TO FILE A TIMELY ELECTION UNDER CODE SECTION 83(b), EVEN IF OPTIONEE REQUESTS THE COMPANY OR ITS REPRESENTATIVES TO MAKE THIS FILING ON HIS OR HER BEHALF. 

  
 Exhibit C -
Page 7 

	G.	GENERAL PROVISIONS 

 1.
Assignment. The Company may assign the Repurchase Right and/or the First Refusal Right to any person or entity selected by the Board, including (without limitation) one or more stockholders of the Company. 

2. At Will Employment. Nothing in this Agreement or in the Plan shall confer upon Optionee any right to continue in Service for
any period of specific duration or interfere with or otherwise restrict in any way the rights of the Company (or any Parent or Subsidiary employing or retaining Optionee) or of Optionee, which rights are hereby expressly reserved by each, to
terminate Optionee’s Service at any time for any reason, with or without cause. 
 3. Notices. Any notice required
to be given under this Agreement shall be in writing and shall be deemed effective upon personal delivery or upon deposit in the U.S. mail, registered or certified, postage prepaid and properly addressed to the party entitled to such notice at the
address indicated below such party’s signature line on this Agreement or at such other address as such party may designate by ten (10) days advance written notice under this paragraph to all other parties to this Agreement. 

Optionee generally consents to the delivery of any notice pursuant to the Texas Business Organizations Code (the
“TBOC”), as amended or superseded from time to time, by electronic transmission pursuant to Section 6.051 of the TBOC (“Electronic Notice”) at the electronic mail address or the facsimile number
as set forth in the books of the Company. To the extent that any notice given via electronic transmission is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected electronic
mail address has been provided, and such attempted Electronic Notice shall be ineffective and deemed to not have been given. Optionee agrees to promptly notify the Company of any change in Optionee’s electronic mail address, but failure to do
so shall not affect the foregoing. 
 4. No Waiver. The failure of the Company in any instance to exercise the Repurchase
Right or the First Refusal Right shall not constitute a waiver of any other repurchase rights and/or rights of first refusal that may subsequently arise under the provisions of this Agreement or any other agreement between the Company and Optionee.
No waiver of any breach or condition of this Agreement shall be deemed to be a waiver of any other or subsequent breach or condition, whether of like or different nature. 
 5. Cancellation of Shares. If the Company shall make available, at the time and place and in the amount and form provided in this Agreement, the consideration for the Purchased Shares to be
repurchased in accordance with the provisions of this Agreement, then from and after such time, the person from whom such shares are to be repurchased shall no longer have any rights as a holder of such shares (other than the right to receive
payment of such consideration in accordance with this Agreement). Such shares shall be deemed purchased in accordance with the applicable provisions hereof, and the Company shall be deemed the owner and holder of such shares, whether or not the
certificates therefor have been delivered as required by this Agreement. 

  
 Exhibit C -
Page 8 

	H.	MISCELLANEOUS PROVISIONS 

1. Optionee Undertaking. Optionee hereby agrees to take whatever additional action and execute whatever additional documents the
Company may deem necessary or advisable in order to carry out or effect one or more of the obligations or restrictions imposed on either Optionee or the Purchased Shares pursuant to the provisions of this Agreement. 

2. Agreement is Entire Contract. This Agreement constitutes the entire contract between the parties hereto with regard to the
subject matter hereof. This Agreement is made pursuant to the provisions of the Plan and shall in all respects be construed in conformity with the terms of the Plan. 
 3. Governing Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Texas without resort to that state’s conflict-of-laws rules. 

4. Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed to be an original, but all of which
together shall constitute one and the same instrument. 
 5. Successors and Assigns. The provisions of this Agreement
shall inure to the benefit of, and be binding upon, the Company and its successors and assigns and upon Optionee, Optionee’s permitted assigns and the legal representatives, heirs and legatees of Optionee’s estate, whether or not any such
person shall have become a party to this Agreement and have agreed in writing to join herein and be bound by the terms hereof. 

[Signature Page Follows] 

  
 Exhibit C -
Page 9 

 IN WITNESS WHEREOF, the parties have executed this Stock Purchase Agreement on the day and
year first indicated above. 
  

			
	WHITEGLOVE HOUSE CALL HEALTH, INC.
	
	 
	By:	 	Robert A. Fabbio
		 	Chief Executive Officer

			
		
	Address:	 	 5300 Bee Cave Road, #1-100

Austin, TX 78746

  

			
	OPTIONEE
	
	 
	«name»
		
	Address:	 	 
		
		 	 

  
 Exhibit C -
Page 1 

 SPOUSAL ACKNOWLEDGMENT 

The undersigned spouse of Optionee has read and hereby approves the foregoing Stock Purchase Agreement. In consideration of the
Company’s granting Optionee the right to acquire the Purchased Shares in accordance with the terms of such Agreement, the undersigned hereby agrees to be irrevocably bound by all the terms of such Agreement, including (without limitation) the
right of the Company (or its assigns) to purchase any Purchased Shares in which Optionee is not vested at time of his or her cessation of Service. 
  

			
	
	 
	OPTIONEE’S SPOUSE
		
	Address:	 	 
		
		 	 

 EXHIBIT I 
 ASSIGNMENT SEPARATE FROM CERTIFICATE 

 ASSIGNMENT SEPARATE FROM CERTIFICATE 

FOR VALUE RECEIVED
                                        
hereby sell(s), assign(s) and transfer(s) unto Whiteglove House Call Health, Inc. (the “Company”),
                     (            ) shares of the Common Stock of the
Company standing in his or her name on the books of the Company represented by Certificate No.                      herewith and do(es) hereby
irrevocably constitute and appoint                          Attorney to transfer the said stock on the books of the
Company with full power of substitution in the premises. 
 Dated:
                     
  

			
	Signature	 	 

 Instruction: Please do not
fill in any blanks other than the signature line. Please sign exactly as you would like your name to appear on the issued stock certificate. The purpose of this assignment is to enable the Company to exercise the Repurchase Right without requiring
additional signatures on the part of Optionee. 

  
 Exhibit C-1

 EXHIBIT II 
 FEDERAL INCOME TAX CONSEQUENCES AND 
 SECTION 83(b) TAX ELECTION

 FEDERAL INCOME TAX CONSEQUENCES AND 

SECTION 83(b) TAX ELECTION 
 I. Federal Income Tax Consequences and Section 83(b) Election For Exercise of Non-Statutory Option. If the Purchased Shares are acquired pursuant to the exercise of a Non-Statutory Option, as
specified in the Grant Notice, then under Code Section 83, the excess of the Fair Market Value of the Purchased Shares on the date any forfeiture restrictions applicable to such shares lapse over the Exercise Price paid for those shares will be
reportable as ordinary income on the lapse date. For this purpose, the term “forfeiture restrictions” includes the right of the Company to repurchase the Purchased Shares pursuant to the Repurchase Right. However, Optionee
may elect under Code Section 83(b) to be taxed at the time the Purchased Shares are acquired, rather than when and as such Purchased Shares cease to be subject to such forfeiture restrictions. Such election must be filed with the Internal
Revenue Service within thirty (30) days after the date of the Agreement. Even if the Fair Market Value of the Purchased Shares on the date of the Agreement equals the Exercise Price paid (and thus no tax is payable), the election must be made
to avoid adverse tax consequences in the future. The form for making this election is attached as part of this exhibit. FAILURE TO MAKE THIS FILING WITHIN THE APPLICABLE THIRTY (30)-DAY PERIOD WILL RESULT IN THE RECOGNITION OF ORDINARY INCOME BY
OPTIONEE AS THE FORFEITURE RESTRICTIONS LAPSE. 
 II. Federal Income Tax Consequences and Conditional Section 83(b)
Election For Exercise of Incentive Option. If the Purchased Shares are acquired pursuant to the exercise of an Incentive Option, as specified in the Grant Notice, then the following tax principles shall be applicable to the Purchased Shares:

 (i) For regular tax purposes, no taxable income will be recognized at the time the Option is exercised.

 (ii) The excess of (a) the Fair Market Value of the Purchased Shares on the date the Option is exercised
or (if later) on the date any forfeiture restrictions applicable to the Purchased Shares lapse over (b) the Exercise Price paid for the Purchased Shares will be includible in Optionee’s taxable income for alternative minimum tax purposes.

 (iii) If Optionee makes a disqualifying disposition of the Purchased Shares, then Optionee will recognize
ordinary income in the year of such disposition equal in amount to the excess of (a) the Fair Market Value of the Purchased Shares on the date the Option is exercised or (if later) on the date any forfeiture restrictions applicable to the
Purchased Shares lapse over (b) the Exercise Price paid for the Purchased Shares. Any additional gain recognized upon the disqualifying disposition will be either short-term or long-term capital gain depending upon the period for which the
Purchased Shares are held prior to the disposition. 
 (iv) For purposes of the foregoing, the term
“forfeiture restrictions” will include the right of the Company to repurchase the Purchased Shares pursuant to the Repurchase Right. The term “disqualifying disposition” means any sale or other

  
 Exhibit
C-II - Page 1 

 
disposition1 of the Purchased Shares within two (2) years after the Grant Date or within one (1) year after the exercise date of the Option. 

(v) The Code Section 83(b) election will be effective in limiting the Optionee’s alternative minimum taxable
income to the excess of the Fair Market Value of the Purchased Shares at the time the Option is exercised over the Exercise Price paid for those shares. 
 Page 2 of the attached form for making the election should be filed with any election made in connection with the exercise of an Incentive Option. 

 
  

	1 	 Generally, a disposition of shares purchased under an Incentive Option includes any transfer of legal title, including a transfer by sale, exchange or
gift, but does not include a transfer to the Optionee’s spouse, a transfer into joint ownership with right of survivorship if Optionee remains one of the joint owners, a pledge, a transfer by bequest or inheritance or certain tax-free exchanges
permitted under the Code. 

  
 Exhibit
C-II - Page 2 

 SECTION 83(b) ELECTION 

This statement is being made under Section 83(b) of the Internal Revenue Code, pursuant to Treas. Reg. Section 1.83-2.

  

	(1)	The taxpayer who performed the services is: 

 Name: 
 Address: 

Taxpayer Ident. No.: 
  

	(2)	The property with respect to which the election is being made is
                     shares of the common stock of Whiteglove House Call Health, Inc. 

 

	(3)	The property was issued on                     ,
        . 

  

	(4)	The taxable year in which the election is being made is the calendar year             .

  

	(5)	The property is subject to a repurchase right pursuant to which the issuer has the right to acquire the property at the lower of the purchase price paid per share or
the fair market value per share, if for any reason taxpayer’s service with the issuer terminates. The issuer’s repurchase right will lapse in a series of annual and monthly installments over a four (4)-year period ending on
                , 20     . 

  

	(6)	The fair market value at the time of transfer (determined without regard to any restriction other than a restriction which by its terms will never lapse) is
$                     per share. 

  

	(7)	The amount paid for such property is $                    
per share. 

  

	(8)	A copy of this statement was furnished to Whiteglove House Call Health, Inc. for whom taxpayer rendered the services underlying the transfer of property.

  

	(9)	This statement is executed on                     ,
        . 

  

					
	  	 		 	  
	Taxpayer	 		 	Spouse (if any)

 This election must be filed with the
Internal Revenue Service Center with which taxpayer files his or her federal income tax returns and must be made within thirty (30) days after the execution date of the Stock Purchase Agreement. This filing should be made by registered or
certified mail, return receipt requested. Optionee must retain two (2) copies of the completed form for filing with his or her federal and state tax returns for the current tax year and an additional copy for his or her records. 

 THIS PAGE 2 IS TO BE ATTACHED TO ANY SECTION 83(b) ELECTION FILED IN CONNECTION WITH THE EXERCISE OF AN
INCENTIVE STOCK OPTION UNDER THE FEDERAL TAX LAWS. 
 The property described in the above Section 83(b) election is
comprised of shares of common stock acquired pursuant to the exercise of an incentive stock option under Section 422 of the Internal Revenue Code (the “Code”). Accordingly, the purpose of this election is to have the
alternative minimum taxable income attributable to the purchased shares measured by the amount by which the fair market value of such shares at the time of their transfer to the Taxpayer exceeds the purchase price paid for the shares. In the absence
of this election, such alternative minimum taxable income would be measured by the spread between the fair market value of the purchased shares and the purchase price which exists on the various lapse dates in effect for the forfeiture restrictions
applicable to such shares. 

 EXHIBIT D 

FORM OF 

2007 STOCK OPTION/STOCK ISSUANCE PLAN 

 WHITEGLOVE HOUSE CALL HEALTH, INC. 

SPECIAL ACCELERATION ADDENDUM 
 TO 
 STOCK OPTION AGREEMENT 

The following provisions are hereby incorporated into, and are hereby made a part of, that certain Stock Option Agreement (the
“Option Agreement”) by and between Whiteglove House Call Health, Inc., a Texas corporation (the “Company”), and «name» (“Optionee”) evidencing the stock option (the
“Option”) granted on «granted» to Optionee under the terms of the Company’s 2007 Stock Option/Stock Issuance Plan, as amended, and such provisions shall be effective immediately. All capitalized terms in this
Addendum, to the extent not otherwise defined herein, shall have the meanings assigned to them in the Option Agreement. 

ACCELERATION OF VESTING IN CONNECTION WITH CHANGE IN CONTROL 
 1. (A) If the Option, to the extent outstanding, shall be (a) assumed (pursuant to the Plan) or otherwise continued in full force and effect pursuant to the terms of the Change in Control transaction
or (b) replaced with a cash retention program of the Company or any successor corporation which preserves the spread existing on the unvested option shares at the time of the Change in Control and provides for subsequent payout of that spread
in accordance with the same vesting schedule applicable to those unvested option shares, then 
  

	 	(1)	50% of the then-remaining unvested shares shall become vested shares (or their equivalent under the equivalent option or right substituted for the option); and

  

	 	(2)	if the Optionee’s service is Involuntarily Terminated (as defined below) at any time during the twelve month period following the consummation of the Change in
Control, all of the then-remaining unvested shares shall become immediately vested and immediately exercisable for a period of 90 days from the date of termination of employment or service, and the option shall terminate upon the expiration of such
period; 

 OR 
 (B) In the event that the successor corporation (or parent thereof) refuses to assume or substitute the option, the option shall become immediately vested and the option shall become immediately
exercisable for all of the shares subject to the option. 
 2. For purposes of this Acceleration Policy, Optionee’s Service is
“Involuntarily Terminated” by reason of: 
  

	 	(1)	Optionee’s involuntary dismissal or discharge for reasons other than for Misconduct, or 

	 	(2)	Optionee’s voluntary resignation following (A) a change in Optionee’s position with the Company (or Parent or Subsidiary employing Optionee) which
materially reduces Optionee’s duties and responsibilities or the level of management to which he or she reports, (B) a reduction in Optionee’s level of compensation (including base salary, fringe benefits and target bonus under any
corporate-performance based incentive programs) by more than fifteen percent (15%) or (C) a relocation of Optionee’s place of employment by more than fifty (50) miles, provided and only if such change, reduction or relocation is
effected by the Company without Optionee’s consent. 

 3. The provisions of this Addendum shall govern the period for which
the Option is to remain exercisable following the Involuntary Termination of Optionee’s Service after the Change in Control and shall supersede any provisions to the contrary in the Option Agreement, including those concerning the deferred
exercisability of the Option. 
 IN WITNESS WHEREOF, Whiteglove House Call Health, Inc. has caused this Addendum to be
executed by its duly-authorized officer as of the Effective Date specified below. 
  

			
	WHITEGLOVE HOUSE CALL HEALTH, INC.
	
	 
	By:	 	Robert A. Fabbio
		 	President and Chief Executive Officer

 EFFECTIVE
DATE:                         ,Form of Notice of Grant-Standard Exercise

 Exhibit 10.5 
 STANDARD 
 WHITEGLOVE HOUSE CALL HEALTH, INC. 

NOTICE OF GRANT OF STOCK OPTION 
 Notice is hereby given of the following option grant (the “Option”) to purchase shares (the “Option Shares”) of the Common Stock of Whiteglove House Call
Health, Inc., a Texas corporation (the “Company”): 
 Optionee: 

Grant Date: 
 Vesting Commencement Date: 
 Exercise Price: 

Number of Option Shares: 
 Expiration Date: 
 Type of Option:
                           Incentive Stock Option  

                    
             Non-Statutory Stock Option 
 Date
Exercisable: The Option shall become exercisable with respect to (i) one-fourth (1/4th) of the Option Shares on the first anniversary of the Vesting Commencement Date and (ii) an additional one forty-eighth (1/48th) of the
Option Shares on the corresponding day of each calendar month thereafter or, if such calendar month does not have a corresponding day, on the last day of such calendar month. The Option shall not become exercisable for any additional Option Shares
following Optionee’s cessation of Service, except to the extent (if any) specifically authorized by the Plan Administrator in its sole discretion pursuant to an express written agreement with Optionee. 

Optionee understands and agrees that the Option is granted subject to and in accordance with the terms of the Whiteglove House Call
Health, Inc. 2007 Stock Option/Stock Issuance Plan (the “Plan”). Optionee further agrees to be bound by the terms of the Plan and the terms of the Option as set forth in the Stock Option Agreement attached hereto as
Exhibit A and the Code Section 409A Waiver and Release attached hereto as Exhibit B. Optionee understands that any Option Shares purchased under the Option will be subject to the terms set forth in the Stock Purchase Agreement
attached hereto as Exhibit C. Optionee hereby acknowledges receipt of a copy of the Plan in the form attached hereto as Exhibit D and receipt of “Questions and Answers about Option Grants” from the Company. 

  

 RIGHT OF FIRST REFUSAL. OPTIONEE HEREBY AGREES THAT ALL OPTION SHARES ACQUIRED UPON
THE EXERCISE OF THE OPTION SHALL BE SUBJECT TO CERTAIN RIGHTS OF FIRST REFUSAL EXERCISABLE BY THE COMPANY AND ITS ASSIGNS. THE TERMS OF SUCH RIGHTS ARE SPECIFIED IN THE ATTACHED STOCK PURCHASE AGREEMENT. 

At Will Employment. Nothing in this Notice or in the attached Stock Option Agreement or Plan shall confer upon Optionee any right
to continue in Service for any period of specific duration or interfere with or otherwise restrict in any way the rights of the Company (or any Parent or Subsidiary employing or retaining Optionee) or of Optionee, which rights are hereby expressly
reserved by each, to terminate Optionee’s Service at any time for any reason, with or without cause. 
 Definitions.
All capitalized terms in this Notice shall have the meaning assigned to them in this Notice, in the attached Stock Option Agreement or in the Plan. 
  

									
	DATED:             ,
            	 		 	WHITEGLOVE HOUSE CALL HEALTH, INC.
					
		 		 		 	By:	 	 
		 		 		 	Title:	 	 
				
		 		 		 	 
		 		 		 	, OPTIONEE

  

									
					
		 		 		 	Address:	 	 
		 		 		 		 	 
		 		 		 	Phone:	 	 
		 		 		 	Email:	 	 

 Attachments: 

Exhibit A - Stock Option Agreement 

Exhibit B - Code Section 409A Waiver and Release 
 Exhibit C - Stock Purchase Agreement 
 Exhibit D - 2007 Stock Option/Stock Issuance Plan

  
 2 

 EXHIBIT A 
 STOCK OPTION AGREEMENT 

  

 STANDARD 
 Whiteglove House Call Health, Inc. 
 STOCK OPTION AGREEMENT

 RECITALS 
 A. The Board has adopted the 2007 Stock Option/Stock Issuance (the “Plan”) for the purpose of retaining the services of selected Employees, non-employee members of the Board or the
board of directors of any Parent or Subsidiary and consultants and other independent advisors in the service of the Company (or any Parent or Subsidiary). 
 B. Optionee is to render valuable services to the Company (or a Parent or Subsidiary), and this Agreement is executed pursuant to, and is intended to carry out the purposes of, the Plan in connection with
the Company’s grant of an option to Optionee. 
 C. All capitalized terms in this Agreement not defined herein shall have
the meaning assigned to them in the Grant Notice or the Plan. 
 NOW, THEREFORE, it is hereby agreed as follows: 

1. Grant of Option. The Company hereby grants to Optionee, as of the date of grant of the option (the “Grant
Date”) as specified in the Notice of Grant of Stock Option accompanying this Agreement, pursuant to which Optionee has been informed of the basic terms of the option evidenced hereby (the “Grant Notice”), an
option to purchase up to the number of Option Shares specified in the Grant Notice. The Option Shares shall be purchasable from time to time during the option term specified in Paragraph 2 at the exercise price payable per Option Share as specified
in the Grant Notice (the “Exercise Price”). 
 2. Option Term. This option shall have a term of
ten (10) years measured from the Grant Date and shall accordingly expire at the close of business on the date on which the option expires as specified in the Grant Notice (the “Expiration Date”), unless sooner terminated
in accordance with Paragraph 5 or 6. 
 3. Limited Transferability. 

(a) This option shall be neither transferable nor assignable by Optionee other than by will or the laws of inheritance
following Optionee’s death and may be exercised, during Optionee’s lifetime, only by Optionee. However, Optionee may designate one or more persons as the beneficiary or beneficiaries of this option, and this option shall, in accordance
with such designation, automatically be transferred to such beneficiary or beneficiaries upon the Optionee’s death while holding this option. Such beneficiary or beneficiaries shall take the transferred option subject to all the terms and
conditions of this Agreement, including (without limitation) the limited time period during which this option may, pursuant to Paragraph 5, be exercised following Optionee’s death. 

(b) If this option is designated a Non-Statutory Option in the Grant Notice, then this option may be assigned in whole or
in part during Optionee’s lifetime to one or more of Optionee’s Family Members or to a trust established for the exclusive benefit of Optionee and/or 

  
 Exhibit A -
Page 1 

 
one or more such Family Members, to the extent such assignment is in connection with the Optionee’s estate plan or pursuant to a domestic relations order. The assigned portion shall be
exercisable only by the person or persons who acquire a proprietary interest in the option pursuant to such assignment. The terms applicable to the assigned portion shall be the same as those in effect for this option immediately prior to such
assignment. 
 4. Dates of Exercise. This option shall become exercisable for the Option Shares in one or more
installments as specified in the Grant Notice. As the option becomes exercisable for such installments, those installments shall accumulate, and the option shall remain exercisable for the accumulated installments until the Expiration Date or sooner
termination of the option term under Paragraph 5 or 6. 
 5. Cessation of Service. The option term specified in Paragraph
2 shall terminate (and this option shall cease to be outstanding) prior to the Expiration Date should any of the following provisions become applicable: 
 (a) Should Optionee cease to remain in Service for any reason (other than death, Disability or Misconduct) while this option is outstanding, then Optionee (or any person or persons to whom this option is
transferred pursuant to a permitted transfer under Paragraph 3) shall have a period of three (3) months (commencing with the date of such cessation of Service) during which to exercise this option, but in no event shall this option be
exercisable at any time after the Expiration Date. 
 (b) Should Optionee die while this option is outstanding,
then the personal representative of Optionee’s estate or the person or persons to whom the option is transferred pursuant to Optionee’s will or the laws of inheritance following Optionee’s death or, if applicable, the person to whom
the option is transferred during Optionee’s lifetime pursuant to a permitted transfer under Paragraph 3 shall have the right to exercise this option. However, if Optionee dies while holding this option and has an effective beneficiary
designation in effect for this option at the time of his or her death, then the designated beneficiary or beneficiaries shall have the exclusive right to exercise this option following Optionee’s death. Any such right to exercise this option
shall lapse, and this option shall cease to be outstanding, upon the earlier of (i) the expiration of the twelve (12)-month period measured from the date of Optionee’s death or (ii) the Expiration Date. 

(c) Should Optionee cease Service by reason of Disability while this option is outstanding, then Optionee (or any person
or persons to whom this option is transferred pursuant to a permitted transfer under Paragraph 3) shall have a period of twelve (12) months (commencing with the date of such cessation of Service) during which to exercise this option. In no
event shall this option be exercisable at any time after the Expiration Date. 
 Note: Exercise of this option on a date
later than three (3) months following cessation of Service due to Disability will result in loss of favorable Incentive Option treatment, unless such Disability constitutes Permanent Disability. In the event that Incentive Option treatment is
not available, this option will be taxed as a Non-Statutory Option upon exercise. 

  
 Exhibit A -
Page 2 

 (d) During the limited period of post-Service exercisability, this option
may not be exercised in the aggregate for more than the number of Option Shares for which this option is exercisable pursuant to the exercise schedule specified in the Grant Notice. The option shall not become exercisable for any additional Option
Shares following Optionee’s cessation of Service, except to the extent (if any) specifically authorized by the Plan Administrator pursuant to an express written agreement with Optionee. Upon the expiration of such limited exercise period or (if
earlier) upon the Expiration Date, this option shall terminate and cease to be outstanding for any vested Option Shares for which the option has not been exercised. 

(e) Should Optionee’s Service be terminated for Misconduct or should Optionee otherwise engage in Misconduct while
this option is outstanding, then this option shall terminate immediately and cease to remain outstanding. 
 6. Special
Acceleration of Option. 
 (a) In the event a Change in Control occurs during Optionee’s period of
Service, the exercisability of this option, to the extent outstanding at such time but not otherwise fully exercisable, shall automatically accelerate so that this option shall, immediately prior to the effective date of the Change in Control,
become exercisable for any or all of the Option Shares at the time subject to this option as fully-vested shares of Common Stock. No such acceleration of this option, however, shall occur if and to the extent: (i) this option is either to be
assumed by the successor corporation (or parent thereof) or otherwise to continue in full force and effect pursuant to the terms of the Change in Control transaction or (ii) this option is to be replaced with a cash retention program of the
successor corporation which preserves the spread existing on the Option Shares for which this option is not exercisable at the time of the Change in Control (the excess of the Fair Market Value of such Option Shares over the aggregate Exercise Price
payable for such shares) and provides for subsequent payout in accordance with the same exercise schedule in effect for the option as set forth in the Grant Notice. 

(b) Immediately following the Change in Control, this option, to the extent not previously exercised, shall terminate and
cease to be outstanding, except to the extent assumed by the successor corporation (or parent thereof) or otherwise continued in full force and effect pursuant to the terms of the Change in Control transaction. 

(c) If this option is assumed in connection with a Change in Control or otherwise continued in effect, then this option
shall be appropriately adjusted, immediately after such Change in Control, to apply to the number and class of securities which would have been issuable to Optionee in consummation of such Change in Control had the option been exercised immediately
prior to such Change in Control, and appropriate adjustments shall also be made to the Exercise Price, provided the aggregate Exercise Price shall remain the same. To the extent the actual holders of the Company’s outstanding Common Stock
receive cash consideration for their Common Stock in consummation of the Change in Control, the successor corporation may, in connection with the assumption or continuation of this option, substitute one or more shares of its own common stock with a
fair market value equivalent to the cash consideration paid per share of Common Stock in such Change in Control. 

  
 Exhibit A -
Page 3 

 (d) This Agreement shall not in any way affect the right of the Company to
adjust, reclassify, reorganize or otherwise change its capital or business structure or to merge, consolidate, dissolve, liquidate or sell or transfer all or any part of its business or assets. 

7. Adjustment in Option Shares. In the event of any of the following transactions affecting the outstanding Common Stock as a
class without the Company’s receipt of consideration: any stock split, stock dividend, spin-off transaction, extraordinary distribution (whether in cash, securities or other property), recapitalization, combination of shares, exchange of shares
or other similar transaction affecting the Common Stock without the Company’s receipt of consideration, then equitable adjustments shall be made to (i) the total number and/or class of securities subject to this option and (ii) the
Exercise Price. The adjustments shall be made by the Plan Administrator in such manner as the Plan Administrator deems appropriate in order to reflect such change and thereby preclude a dilution or enlargement of benefits hereunder. 

8. Stockholder Rights. The holder of this option shall not have any stockholder rights with respect to the Option Shares until
such person shall have exercised the option, paid the Exercise Price and become the record holder of the purchased shares. 
 9.
Manner of Exercising Option. 
 (a) In order to exercise this option with respect to all or any part of
the Option Shares for which this option is at the time exercisable, Optionee (or any other person or persons exercising the option) must take the following actions: 

(i) Execute and deliver to the Company a stock purchase agreement in substantially the form of Exhibit C to the
Grant Notice (a “Purchase Agreement”) for the Option Shares for which the option is exercised. 
 (ii) Pay the aggregate Exercise Price for the purchased shares in one or more of the following forms: 
 (A) cash or check made payable to the Company; or 
 (B) a
promissory note payable to the Company, but only to the extent authorized by the Plan Administrator in accordance with Paragraph 14. 
 Should the Common Stock be registered under Section 12 of the 1934 Act at the time the option is exercised, then the Exercise Price may also be paid as follows: 

(C) in shares of Common Stock valued at Fair Market Value on the date on which the options shall have been exercised in
accordance with this Paragraph 9 (the “Exercise Date”) and held by Optionee (or any other person or persons exercising the option) for the period (if any) necessary to avoid a charge to the Company’s earnings for
financial reporting purposes; or 

  
 Exhibit A -
Page 4 

 (D) through a special sale and remittance procedure pursuant to which
Optionee (or any other person or persons exercising the option) shall concurrently provide irrevocable instructions (a) to a brokerage firm (reasonably satisfactory to the Company for purposes of administering such procedure in compliance with
any applicable pre-clearance or pre-notification requirements) to effect the immediate sale of the purchased shares and remit to the Company, out of the sale proceeds available on the settlement date, sufficient funds to cover the aggregate Exercise
Price payable for the purchased shares plus all applicable income and employment taxes required to be withheld by the Company by reason of such exercise and (b) to the Company to deliver the certificates for the purchased shares directly to
such brokerage firm on such settlement date in order to complete the sale. 
 Except to the extent the sale and
remittance procedure is utilized in connection with the option exercise, payment of the Exercise Price must accompany the Purchase Agreement delivered to the Company in connection with the option exercise. 

(iii) Furnish to the Company appropriate documentation that the person or persons exercising the option (if other than
Optionee) have the right to exercise this option. 
 (iv) Execute and deliver to the Company such written
representations as may be requested by the Company in order for it to comply with the applicable requirements of applicable securities laws. 
 (v) Make appropriate arrangements with the Company (or Parent or Subsidiary employing or retaining Optionee) for the satisfaction of all applicable income and employment tax withholding requirements
applicable to the option exercise. 
 (b) As soon as practical after the Exercise Date, the Company shall issue
to or on behalf of Optionee (or any other person or persons exercising this option) a certificate for the purchased Option Shares, with the appropriate legends affixed thereto. 

(c) In no event may this option be exercised for any fractional shares. 

10. RIGHT OF FIRST REFUSAL. ALL OPTION SHARES ACQUIRED UPON THE EXERCISE OF THIS OPTION SHALL BE SUBJECT TO CERTAIN RIGHTS OF
FIRST REFUSAL OF THE COMPANY AND ITS ASSIGNS TO REPURCHASE THOSE SHARES IN ACCORDANCE WITH THE TERMS SPECIFIED IN THE PURCHASE AGREEMENT. 
 11. Compliance with Laws and Regulations. 
 (a) The exercise
of this option and the issuance of the Option Shares upon such exercise shall be subject to compliance by the Company and Optionee with all applicable requirements of law relating thereto and with all applicable regulations of any stock exchange (or
the Nasdaq National Market, if applicable) on which the Common Stock may be listed for trading at the time of such exercise and issuance. 

  
 Exhibit A -
Page 5 

 (b) The inability of the Company to obtain approval from any regulatory body
having authority deemed by the Company to be necessary to the lawful issuance and sale of any Common Stock pursuant to this option shall relieve the Company of any liability with respect to the non-issuance or sale of the Common Stock as to which
such approval shall not have been obtained. The Company, however, shall use its best efforts to obtain all such approvals. 

12. Successors and Assigns. Except to the extent otherwise provided in Paragraphs 3 and 6, the provisions of this Agreement shall
inure to the benefit of, and be binding upon, the Company and its successors and assigns and Optionee, Optionee’s assigns and the legal representatives, heirs and legatees of Optionee’s estate. 

13. Notices. Any notice required to be given or delivered to the Company under the terms of this Agreement shall be in writing and
addressed to the Company at its principal corporate offices. Any notice required to be given or delivered to Optionee shall be in writing and addressed to Optionee at the address indicated below Optionee’s signature line on the Grant Notice.
All notices shall be deemed effective upon personal delivery or upon deposit in the U.S. mail, postage prepaid and properly addressed to the party to be notified. 

Optionee generally consents to the delivery of any notice pursuant to the Texas Business Organizations Code (the
“TBOC”), as amended or superseded from time to time, by electronic transmission pursuant to Section 6.051 of the TBOC (“Electronic Notice”) at the electronic mail address or the facsimile number
as set forth in the books of the Company. To the extent that any notice given via electronic transmission is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected electronic
mail address has been provided, and such attempted Electronic Notice shall be ineffective and deemed to not have been given. Optionee agrees to promptly notify the Company of any change in Optionee’s electronic mail address, but failure to do
so shall not affect the foregoing. 
 14. Financing. The Plan Administrator may, in its absolute discretion and without
any obligation to do so, permit Optionee to pay the Exercise Price for the purchased Option Shares by delivering a full-recourse promissory note bearing interest at a market rate and secured by those Option Shares. The payment schedule in effect for
any such promissory note shall be established by the Plan Administrator in its sole discretion. 
 15. Construction. This
Agreement and the option evidenced hereby are made and granted pursuant to the Plan and are in all respects limited by and subject to the terms of the Plan. All decisions of the Plan Administrator with respect to any question or issue arising under
the Plan or this Agreement shall be conclusive and binding on all persons having an interest in this option. 
 16. Governing
Law. The interpretation, performance and enforcement of this Agreement shall be governed by the laws of the State of Texas without resort to that state’s conflict-of-laws rules. 

17. Stockholder Approval. If the Option Shares covered by this Agreement exceed, as of the Grant Date, the number of shares of
Common Stock which may be issued under the 

  
 Exhibit A -
Page 6 

 
Plan as last approved by the stockholders, then this option shall be void with respect to such excess shares, unless stockholder approval of an amendment sufficiently increasing the number of
shares of Common Stock issuable under the Plan is obtained in accordance with the provisions of the Plan. 
 18. Additional
Terms Applicable to an Incentive Option. In the event this option is designated an Incentive Option in the Grant Notice, the following terms and conditions shall also apply to the grant: 

(a) This option shall cease to qualify for favorable tax treatment as an Incentive Option if (and to the extent) this
option is exercised for one or more Option Shares: (i) more than three (3) months after the date Optionee ceases to be an Employee for any reason other than death or Permanent Disability or (ii) more than twelve (12) months after
the date Optionee ceases to be an Employee by reason of Permanent Disability. 
 (b) No installment under this
option shall qualify for favorable tax treatment as an Incentive Option if (and to the extent) the aggregate Fair Market Value (determined at the Grant Date) of the Common Stock for which such installment first becomes exercisable hereunder would,
when added to the aggregate value (determined as of the respective date or dates of grant) of any earlier installments of the Common Stock and any other securities for which this option or any other Incentive Options granted to Optionee prior to the
Grant Date (whether under the Plan or any other option plan of the Company or any Parent or Subsidiary) first become exercisable during the same calendar year, exceed One Hundred Thousand Dollars ($100,000) in the aggregate. Should such One Hundred
Thousand Dollar ($100,000) limitation be exceeded in any calendar year, this option shall nevertheless become exercisable for the excess shares in such calendar year as a Non-Statutory Option. 

(c) Should Optionee hold, in addition to this option, one or more other options to purchase Common Stock which become
exercisable for the first time in the same calendar year as this option, then for purposes of the foregoing limitations on the exercisability of such options as Incentive Options, this option and each of those other options shall be deemed to become
first exercisable in that calendar year on the basis of the chronological order in which they were granted, except to the extent otherwise provided under applicable law or regulation. 

  
 Exhibit A -
Page 7 

 EXHIBIT B 
 CODE SECTION 409A WAIVER AND RELEASE 

  

 STANDARD 
 Whiteglove House Call Health, Inc. 
 CODE SECTION 409A WAIVER AND RELEASE

 THIS WAIVER AND RELEASE (this “Waiver”) made as of this
             day of             , 20     , by
            , the holder of a stock option under the Company’s 2007 Stock Option/Stock Issuance Plan. 
 All capitalized terms in this Waiver not defined herein shall have the meaning assigned to them in the Notice to which this Waiver is attached or in the Plan. 

Optionee hereby agrees and acknowledges that the Company’s Board has taken reasonable steps to value the Common Stock and to set the
Exercise Price at the Fair Market Value per share of Common Stock on the Grant Date so that the Option will not be treated as an item of deferred compensation subject to Code Section 409A. However, because the Common Stock is not readily
tradable on an established securities market, there can be no assurance that the Exercise Price is at least equal to the Fair Market Value per share of Common Stock on the Grant Date. Were the Internal Revenue Service to conclude that the Exercise
Price is in fact less than such Fair Market Value and that the Option is accordingly subject to Code Section 409A, then Optionee would be subject the following adverse tax consequences: 

(i) As the Option vests in accordance with the Vesting Schedule, Optionee would immediately recognize taxable income for
federal income tax purposes equal to the amount by which the Fair Market Value of the Option Shares which vest at that time exceeds the Exercise Price payable for those shares. The Company would also have to collect from Optionee the federal income
and employment taxes which must be withheld on that income. Taxation would occur in this manner even though the Option remains unexercised. 
 (ii) Optionee may also be subject to additional income taxation and withholding taxes on any subsequent increases to the Fair Market Value of the Option Shares purchasable under the vested Option until
the Option is exercised or cancelled as to those Option Shares. 
 (iii) In addition to normal income taxes
payable as the Option vests, Optionee would also be subject to an additional tax penalty equal to 20% of the amount of income Optionee recognizes under Code Section 409A when the Option vests and may also be subject to such penalty as the
underlying Option Shares subsequently increase in Fair Market Value over the period the Option continues to remain outstanding. 
 (iv) There will also be interest penalties if the resulting taxes are not paid on a timely basis. 
 Optionee hereby further agrees and acknowledges that Optionee will incur the same tax consequences, including (without limitation) a second 20% penalty tax, under California income tax laws if Optionee is
a resident of the State of California or is otherwise subject to California income taxation. If the Optionee is a resident of any other state, he or she accepts the risk of any unfavorable tax consequences under the laws of that state applicable to
options granted with an Exercise Price less than the Fair Market Value of the Option Shares on the Grant Date. 

  
 Exhibit B -
Page 1 

 Optionee hereby agrees to bear the entire risk of such adverse federal and state tax
consequences in the event the Option is deemed to be subject to Code Section 409A and hereby knowingly and voluntarily, in consideration for the grant of the Option, waives and releases any and all claims or causes of action that Optionee might
otherwise have against the Company and/or the Board, officers, employees or stockholders arising from or relating to the tax treatment of the Option under Code Section 409A and the corresponding provisions of any applicable state income tax
laws (including, without limitation, California income tax laws) and shall not seek any indemnification or other recovery of damages against the Company and/or the Board, officers, employees or stockholders with respect to any adverse federal and
state tax consequences or other related costs and expenses Optionee may in fact incur under Code Section 409A (or the corresponding provisions of state income tax laws) as a result of the Option. 

IN WITNESS WHEREOF, the undersigned Optionee has executed this Waiver on the date and year first indicated above. 

 

			
	
	 
	, OPTIONEE
		
	Address: 	 	 
		 	 

  
 Exhibit B -
Page 2 

 EXHIBIT C 
 STOCK PURCHASE AGREEMENT 

  

 STANDARD 
 Whiteglove House Call Health, Inc. 
 STOCK PURCHASE AGREEMENT

 AGREEMENT made this              day of
            ,              by and between Whiteglove House Call Health, Inc., a Texas corporation, and
                    , Optionee under the Company’s 2007 Stock Option/Stock Issuance Plan. 

All capitalized terms in this Agreement shall have the meaning assigned to them in this Agreement or in the Plan attached as Exhibit
D to the Notice of Grant to which this Agreement relates. 
  

	A.	EXERCISE OF OPTION 

 1.
Exercise. Optionee hereby purchases          shares of Common Stock (the “Purchased Shares”) pursuant to that certain option (the “Option”) granted
Optionee on             ,             (the “Grant Date”) to purchase up to
         shares of Common Stock (the “Option Shares”) under the Plan at the exercise price of $             per
share (the “Exercise Price”). 
 2. Payment. Concurrently with the delivery of this Agreement to
the Company, Optionee shall pay the Exercise Price for the Purchased Shares in accordance with the provisions of the all agreements and other documents evidencing the Option (the “Option Agreement”) and shall deliver whatever
additional documents may be required by the Option Agreement as a condition for exercise. 
 3. Stockholder Rights. Until
such time as the Company exercises the First Refusal Right, Optionee (or any successor in interest) shall have all the rights of a stockholder (including voting, dividend and liquidation rights) with respect to the Purchased Shares, subject,
however, to the transfer restrictions of Articles B and C. 
 4. Information. Optionee believes it has received all
the information it considers necessary or appropriate for deciding whether to purchase the Purchased Shares. Optionee further represents that such Optionee has had an opportunity to ask questions and receive answers from the Company regarding the
terms and conditions of the offering of the Purchased Shares and the business, properties, prospects and financial condition of the Company. Optionee acknowledges that it has been furnished separately “Questions and Answers about Option
Grants” by the Company. 
  

	B.	SECURITIES LAW COMPLIANCE 

1. Restricted Securities. The Purchased Shares have not been registered under the Securities Act of 1933, as amended (the
“1933 Act”), and are being issued to Optionee in reliance upon the exemption from such registration provided by Rule 701 of the Securities and Exchange Commission (the “SEC”) for stock issuances under
compensatory benefit plans such as the Plan. Optionee hereby confirms that Optionee has been informed that the Purchased Shares are restricted securities under the 1933 Act and may not be resold or transferred unless the Purchased Shares are first
registered under the federal securities laws or unless an exemption 

  
 Exhibit C -
Page 1 

 
from such registration is available. Accordingly, Optionee hereby acknowledges that Optionee is acquiring the Purchased Shares for investment purposes only and not with a view to resale and is
prepared to hold the Purchased Shares for an indefinite period and that Optionee is aware that SEC Rule 144 issued under the 1933 Act which exempts certain resales of unrestricted securities is not presently available to exempt the resale of the
Purchased Shares from the registration requirements of the 1933 Act. 
 2. Restrictions on Disposition of Purchased
Shares. Optionee shall make no disposition of the Purchased Shares (other than a Permitted Transfer) unless and until there is compliance with all of the following requirements: 

(i) Optionee shall have provided the Company with a written summary of the terms and conditions of the proposed
disposition. 
 (ii) Optionee shall have complied with all requirements of this Agreement applicable to the
disposition of the Purchased Shares. 
 (iii) Optionee shall have provided the Company with written assurances,
in form and substance satisfactory to the Company, that (a) the proposed disposition does not require registration of the Purchased Shares under the 1933 Act or (b) all appropriate action necessary for compliance with the registration
requirements of the 1933 Act or any exemption from registration available under the 1933 Act (including Rule 144) has been taken. 
 The Company shall not be required (i) to transfer on its books any Purchased Shares which have been sold or transferred in violation of the provisions of this Agreement or (ii) to treat as the
owner of the Purchased Shares, or otherwise to accord voting, dividend or liquidation rights to, any transferee to whom the Purchased Shares have been transferred in contravention of this Agreement. 

3. Restrictive Legends. The stock certificates for the Purchased Shares shall be endorsed with one or more of the following
restrictive legends: 
 THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933. THE
SHARES MAY NOT BE SOLD OR OFFERED FOR SALE IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SHARES UNDER SUCH ACT, (B) A ‘NO ACTION’ LETTER OF THE SECURITIES AND EXCHANGE COMMISSION WITH RESPECT TO SUCH SALE OR
OFFER OR (C) SATISFACTORY ASSURANCES TO THE COMPANY THAT REGISTRATION UNDER SUCH ACT IS NOT REQUIRED WITH RESPECT TO SUCH SALE OR OFFER. 
 THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RIGHTS OF FIRST REFUSAL GRANTED TO THE COMPANY AND ACCORDINGLY MAY NOT BE SOLD, ASSIGNED, TRANSFERRED, ENCUMBERED, OR IN ANY MANNER
DISPOSED OF EXCEPT IN CONFORMITY WITH THE TERMS OF A STOCK PURCHASE 

  
 Exhibit C -
Page 2 

 
AGREEMENT BETWEEN THE COMPANY AND THE REGISTERED HOLDER OF THE SHARES (OR THE PREDECESSOR IN INTEREST TO THE SHARES). A COPY OF SUCH AGREEMENT IS MAINTAINED AT THE COMPANY’S PRINCIPAL
CORPORATE OFFICES. 
  

	C.	TRANSFER RESTRICTIONS 

 1.
Restriction on Transfer. Except for any Permitted Transfer, Optionee shall not transfer, assign, encumber or otherwise dispose of any of the Purchased Shares in contravention of the First Refusal Right or the Market Stand-Off. 

2. Transferee Obligations. Each person (other than the Company) to whom the Purchased Shares are transferred by means of a
Permitted Transfer must, as a condition precedent to the validity of such transfer, acknowledge in writing to the Company that such person is bound by the provisions of this Agreement and that the transferred shares are subject to (i) the First
Refusal Right and (ii) the Market Stand-Off, to the same extent such shares would be so subject if retained by Optionee. 

3. Market Stand-Off. 
 (a) In connection with any underwritten public offering by the Company of its equity securities pursuant to an effective registration statement filed under the 1933 Act, including the Company’s
initial public offering, Optionee and all subsequent holders of the Purchased Shares who derive their chain of ownership through a Permitted Transfer from Optionee (the “Owner”) shall not (i) lend, offer, pledge, sell,
contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any securities of the Company, including
(without limitation) shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock (whether now owned or hereafter acquired) or (ii) enter into any swap or other arrangement that transfers to another,
in whole or in part, any of the economic consequences of ownership of any securities of the Company, including (without limitation) shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock (whether
now owned or hereafter acquired), whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of securities, in cash or otherwise without the prior written consent of the Company or its
underwriters. Such restriction (the “Market Stand-Off”) shall be in effect for such period of time from and after the effective date of the final prospectus for the offering as may be requested by the Company or such
underwriters. In no event, however, shall such period exceed one hundred eighty (180) days, and the Market Stand-Off shall in no event be applicable to any underwritten public offering effected more than two (2) years after the effective
date of the Company’s initial public offering. 
 (b) Owner shall be subject to the Market Stand-Off
provided and only if the officers and directors of the Company are also subject to similar restrictions. 
 (c)
Any new, substituted or additional securities which are by reason of any Recapitalization or Reorganization distributed with respect to the Purchased Shares shall be immediately subject to the Market Stand-Off, to the same extent the Purchased
Shares are at such time covered by such provisions. 

  
 Exhibit C -
Page 3 

 (d) In order to enforce the Market Stand-Off, the Company may impose
stop-transfer instructions with respect to the Purchased Shares until the end of the applicable stand-off period. 
  

	D.	RIGHT OF FIRST REFUSAL 

1. Grant. The Company is hereby granted the right of first refusal (the “First Refusal Right”), exercisable
in connection with any proposed transfer of the Purchased Shares. For purposes of this Article D, the term “transfer” shall include any sale, assignment, pledge, encumbrance or other disposition of the Purchased Shares
intended to be made by Owner, but shall not include any Permitted Transfer. 
 2. Notice of Intended Disposition. In the
event any Owner of Purchased Shares desires to accept a bona fide third-party offer for the transfer of any or all of such shares (the Purchased Shares subject to such offer to be hereinafter referred to as the “Target
Shares”), Owner shall promptly (i) deliver to the Company written notice (the “Disposition Notice”) of the terms of the offer, including the purchase price and the identity of the third-party offeror, and
(ii) provide satisfactory proof that the disposition of the Target Shares to such third-party offeror would not be in contravention of the provisions set forth in Articles B and C. 

3. Exercise of the First Refusal Right. The Company shall, for a period of twenty-five (25) days following receipt of the
Disposition Notice, have the right to repurchase any or all of the Target Shares subject to the Disposition Notice upon the same terms as those specified therein or upon such other terms (not materially different from those specified in the
Disposition Notice) to which Owner consents. Such right shall be exercisable by delivery of written notice (the “Exercise Notice”) to Owner prior to the expiration of the twenty-five (25)-day exercise period. If such right is
exercised with respect to all the Target Shares, then the Company shall effect the repurchase of such shares, including payment of the purchase price, not more than five (5) business days after delivery of the Exercise Notice; and at such time
the certificates representing the Target Shares shall be delivered to the Company. 
 Should the purchase price
specified in the Disposition Notice be payable in property other than cash or evidences of indebtedness, the Company shall have the right to pay the purchase price in the form of cash equal in amount to the value of such property. If Owner and the
Company cannot agree on such cash value within ten (10) days after the Company’s receipt of the Disposition Notice, the valuation shall be made by an appraiser of recognized standing selected by Owner and the Company or, if they cannot
agree on an appraiser within twenty (20) days after the Company’s receipt of the Disposition Notice, each shall select an appraiser of recognized standing and the two (2) appraisers shall designate a third appraiser of recognized
standing, whose appraisal shall be determinative of such value. The cost of such appraisal shall be shared equally by Owner and the Company. The closing shall then be held on the later of (i) the fifth (5th) business day following delivery
of the Exercise Notice or (ii) the fifth (5th) business day after such valuation shall have been made. 

  
 Exhibit C -
Page 4 

 4. Non-Exercise of the First Refusal Right. In the event the Exercise Notice is not
given to Owner prior to the expiration of the twenty-five (25)-day exercise period, Owner shall have a period of thirty (30) days thereafter in which to sell or otherwise dispose of the Target Shares to the third-party offeror identified in the
Disposition Notice upon terms (including the purchase price) no more favorable to such third-party offeror than those specified in the Disposition Notice; provided, however, that any such sale or disposition must not be effected in
contravention of the provisions of Articles B and C. The third-party offeror shall acquire the Target Shares subject to the First Refusal Right and the provisions and restrictions of Article B and Paragraph C.3, and any subsequent
disposition of the acquired shares must be effected in compliance with the terms and conditions of such First Refusal Right and the provisions and restrictions of Article B and Paragraph C.3. In the event Owner does not effect such sale or
disposition of the Target Shares within the specified thirty (30)-day period, the First Refusal Right shall continue to be applicable to any subsequent disposition of the Target Shares by Owner until such right lapses. 

5. Partial Exercise of the First Refusal Right. In the event the Company makes a timely exercise of the First Refusal Right with
respect to a portion, but not all, of the Target Shares specified in the Disposition Notice, Owner shall have the option, exercisable by written notice to the Company delivered within five (5) business days after Owner’s receipt of the
Exercise Notice, to effect the sale of the Target Shares pursuant to either of the following alternatives: 
 (i)
sale or other disposition of all the Target Shares to the third-party offeror identified in the Disposition Notice, but in full compliance with the requirements of Paragraph D.4, as if the Company did not exercise the First Refusal Right; or

 (ii) sale to the Company of the portion of the Target Shares which the Company has elected to purchase, such
sale to be effected in substantial conformity with the provisions of Paragraph D.3. The First Refusal Right shall continue to be applicable to any subsequent disposition of the remaining Target Shares until such right lapses. 

Owner’s failure to deliver timely notification to the Company shall be deemed to be an election by Owner to sell the Target Shares
pursuant to alternative (i) above. 
 6. Recapitalization/Reorganization. 

(a) Any new, substituted or additional securities or other property which is by reason of any Recapitalization distributed
with respect to the Purchased Shares shall be immediately subject to the First Refusal Right, but only to the extent the Purchased Shares are at the time covered by such right. 

(b) In the event of a Reorganization, the First Refusal Right shall remain in full force and effect and shall apply to the
new capital stock or other property received in exchange for the Purchased Shares in consummation of the Reorganization, but only to the extent the Purchased Shares are at the time covered by such right. 

7. Lapse. The First Refusal Right shall lapse upon the earliest to occur of (i) the first date on which shares of the
Common Stock are held of record by more than five hundred (500)

  
 Exhibit C -
Page 5 

 
persons, (ii) a determination made by the Board that a public market exists for the outstanding shares of Common Stock, (iii) a firm commitment underwritten public offering, pursuant to
an effective registration statement under the 1933 Act, covering the offer and sale of the Common Stock in the aggregate amount of at least twenty million dollars ($20,000,000) or (iv) the closing of a Change in Control. However, the Market
Stand-Off shall continue to remain in full force and effect following the lapse of the First Refusal Right. 
  

	E.	GENERAL PROVISIONS 

 1.
Assignment. The Company may assign the First Refusal Right to any person or entity selected by the Board, including (without limitation) one or more stockholders of the Company. 

2. At Will Employment. Nothing in this Agreement or in the Plan shall confer upon Optionee any right to continue in Service for
any period of specific duration or interfere with or otherwise restrict in any way the rights of the Company (or any Parent or Subsidiary employing or retaining Optionee) or of Optionee, which rights are hereby expressly reserved by each, to
terminate Optionee’s Service at any time for any reason, with or without cause. 
 3. Notices. Any notice required
to be given under this Agreement shall be in writing and shall be deemed effective upon personal delivery or upon deposit in the U.S. mail, registered or certified, postage prepaid and properly addressed to the party entitled to such notice at the
address indicated below such party’s signature line on this Agreement or at such other address as such party may designate by ten (10) days advance written notice under this paragraph to all other parties to this Agreement. 

Optionee generally consents to the delivery of any notice pursuant to the Texas Business Organizations Code (the
“TBOC”), as amended or superseded from time to time, by electronic transmission pursuant to Section 6.051 of the TBOC (“Electronic Notice”) at the electronic mail address or the facsimile number
as set forth in the books of the Company. To the extent that any notice given via electronic transmission is returned or undeliverable for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected electronic
mail address has been provided, and such attempted Electronic Notice shall be ineffective and deemed to not have been given. Optionee agrees to promptly notify the Company of any change in Optionee’s electronic mail address, but failure to do
so shall not affect the foregoing. 
 4. No Waiver. The failure of the Company in any instance to exercise the Repurchase
Right or the First Refusal Right shall not constitute a waiver of any other rights of first refusal that may subsequently arise under the provisions of this Agreement or any other agreement between the Company and Optionee. No waiver of any breach
or condition of this Agreement shall be deemed to be a waiver of any other or subsequent breach or condition, whether of like or different nature. 

  
 Exhibit C -
Page 6 

 5. Cancellation of Shares. If the Company shall make available, at the time and place
and in the amount and form provided in this Agreement, the consideration for the Purchased Shares to be repurchased in accordance with the provisions of this Agreement, then from and after such time, the person from whom such shares are to be
repurchased shall no longer have any rights as a holder of such shares (other than the right to receive payment of such consideration in accordance with this Agreement). Such shares shall be deemed purchased in accordance with the applicable
provisions hereof, and the Company shall be deemed the owner and holder of such shares, whether or not the certificates therefor have been delivered as required by this Agreement. 

 

	F.	MISCELLANEOUS PROVISIONS 

1. Optionee Undertaking. Optionee hereby agrees to take whatever additional action and execute whatever additional documents the
Company may deem necessary or advisable in order to carry out or effect one or more of the obligations or restrictions imposed on either Optionee or the Purchased Shares pursuant to the provisions of this Agreement. 

2. Agreement is Entire Contract. This Agreement constitutes the entire contract between the parties hereto with regard to the
subject matter hereof. This Agreement is made pursuant to the provisions of the Plan and shall in all respects be construed in conformity with the terms of the Plan. 
 3. Governing Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Texas without resort to that state’s conflict-of-laws rules. 

4. Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed to be an original, but all of which
together shall constitute one and the same instrument. 
 5. Successors and Assigns. The provisions of this Agreement
shall inure to the benefit of, and be binding upon, the Company and its successors and assigns and upon Optionee, Optionee’s permitted assigns and the legal representatives, heirs and legatees of Optionee’s estate, whether or not any such
person shall have become a party to this Agreement and have agreed in writing to join herein and be bound by the terms hereof. 

[Signature Page Follows] 

  
 Exhibit C -
Page 7 

 IN WITNESS WHEREOF, the parties have executed this Stock Purchase Agreement on the day and
year first indicated above. 
  

			
	Whiteglove House Call Health, Inc.
		
	By:	 	 
	Title:	 	 
	Address: 	 	 
		 	 

  

			
	
	 
	, OPTIONEE
		
	Address: 	 	 
		 	 

  
 Exhibit C -
Page 1 

 EXHIBIT D 

FORM OF 

2007 STOCK OPTION/STOCK ISSUANCE PLAN 

  

 WHITEGLOVE HOUSE CALL HEALTH, INC. 

SPECIAL ACCELERATION ADDENDUM 
 TO 
 STOCK OPTION AGREEMENT 

The following provisions are hereby incorporated into, and are hereby made a part of, that certain Stock Option Agreement (the
“Option Agreement”) by and between Whiteglove House Call Health, Inc., a Texas corporation (the “Company”), and «name» (“Optionee”) evidencing the stock option (the
“Option”) granted on «granted» to Optionee under the terms of the Company’s 2007 Stock Option/Stock Issuance Plan, as amended, and such provisions shall be effective immediately. All capitalized terms in this
Addendum, to the extent not otherwise defined herein, shall have the meanings assigned to them in the Option Agreement. 

ACCELERATION OF VESTING IN CONNECTION WITH CHANGE IN CONTROL 
 1. (A) If the Option, to the extent outstanding, shall be (a) assumed (pursuant to the Plan) or otherwise continued in full force and effect pursuant to the terms of the Change in Control transaction
or (b) replaced with a cash retention program of the Company or any successor corporation which preserves the spread existing on the unvested option shares at the time of the Change in Control and provides for subsequent payout of that spread
in accordance with the same vesting schedule applicable to those unvested option shares, then 
  

	 	(1)	50% of the then-remaining unvested shares shall become vested shares (or their equivalent under the equivalent option or right substituted for the option); and

  

	 	(2)	if the Optionee’s service is Involuntarily Terminated (as defined below) at any time during the twelve month period following the consummation of the Change in
Control, all of the then-remaining unvested shares shall become immediately vested and immediately exercisable for a period of 90 days from the date of termination of employment or service, and the option shall terminate upon the expiration of such
period; 

 OR 
 (B) In the event that the successor corporation (or parent thereof) refuses to assume or substitute the option, the option shall become immediately vested and the option shall become immediately
exercisable for all of the shares subject to the option. 
 2. For purposes of this Acceleration Policy, Optionee’s Service is
“Involuntarily Terminated” by reason of: 

  

	 	(1)	Optionee’s involuntary dismissal or discharge for reasons other than for Misconduct, or 

 

	 	(2)	Optionee’s voluntary resignation following (A) a change in Optionee’s position with the Company (or Parent or Subsidiary employing Optionee) which
materially reduces Optionee’s duties and responsibilities or the level of management to which he or she reports, (B) a reduction in Optionee’s level of compensation (including base salary, fringe benefits and target bonus under any
corporate-performance based incentive programs) by more than fifteen percent (15%) or (C) a relocation of Optionee’s place of employment by more than fifty (50) miles, provided and only if such change, reduction or relocation is
effected by the Company without Optionee’s consent. 

 3. The provisions of this Addendum shall govern the period for which
the Option is to remain exercisable following the Involuntary Termination of Optionee’s Service after the Change in Control and shall supersede any provisions to the contrary in the Option Agreement, including those concerning the deferred
exercisability of the Option. 
 IN WITNESS WHEREOF, Whiteglove House Call Health, Inc. has caused this Addendum to be
executed by its duly-authorized officer as of the Effective Date specified below. 
  

			
	WHITEGLOVE HOUSE CALL HEALTH, INC.
		
	By:	 	/s/ Robert A. Fabbio
		 	Robert A. Fabbio
		 	President

 EFFECTIVE DATE:
                        ,

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00188-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00188-of-00352.parquet"}]]